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ABSTRACT
Saudi Arabia is among the countries that have very high prevalence rates of diabetes and
hypertension, with prevalence rates of almost 18% and 25%, respectively. The majority of
patients with diabetes and hypertension fail to manage their diseases and to show up for their
follow up appointments. Mhealth technology is among the interventions that have been recently
adopted to overcome these issues and improve the quality of healthcare services. This study aims
to evaluate the effectiveness of a mobile phone application named diabetes and hypertension
application (DHA Tracking) to promote adherence for patients with diabetes and hypertension in
Mecca, Saudi Arabia. The proposed intervention was designed to promote adherence via two
features, namely, refill medication reminder (RMR) and doctor appointment reminder (DAR).
The third feature, which is managing the number of unnecessary visits, was covered by the
cumulative blood sugar test (Hemoglobin A1c) for patients with their doctors. The study
examined the difference in adherence level before the intervention and after the intervention with
samples of n = 199 and n = 165 for diabetes and hypertension, respectively. The mhealth
intervention was found to have significant effects on both the refill medication reminder and the
doctor's appointment reminder. Also, it was found that the intervention was efficient in reducing
the number of unnecessary follow-up visits to around 20%. This study supports the evidence in
the literature on the effectiveness of mhealth in promoting adherence to medication for patients
with chronic diseases in the developing countries and specifically in Saudi Arabia. Positive
social change that may result from this study is for better management of chronic disease
symptoms and increase the awareness of using mhealth applications. This would improve the
quality of life for patients, their families, and the community.
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CHAPTER ONE: INTRODUCTION
1.1

Introduction to Topic

Chronic diseases, such as diabetes and hypertension, have reached epidemic rates
worldwide. According to the International Diabetes Federation (IDF) DIABETES ATLAS 2017,
around half a billion people worldwide live with diabetes. Also, the majority of those diagnosed
with diabetes live in medium to low-income countries. Similarly, hypertension affects more than
one billion people globally (World Health Organization, 2013).
The diagnosis and treatment of chronic diseases require prolonged care and management
from both patients and the healthcare facilities where patients receive health services. Such
diseases increased the burden on the healthcare systems in developing countries where medical,
financial, and human resources are limited (Allegranzi et al., 2011). Subsequently, in such a
situation, providing high-quality healthcare services to patients with chronic diseases such as
diabetes and hypertension became very challenging.
In an effort to deal with past challenges, many scholars and healthcare providers have
initiated several health interventions to provide high-quality services to patients with a variety of
diseases. Among those interventions that have widely been adopted recently is mobile health
“mhealth.” The mhealth is defined as the use of cell phone and wireless technologies to provide
medical care services (Agarwal et al., 2016). Mobile technologies include devices such as
“mobile phones; personal digital assistants (PDA) and PDA phones (e.g., BlackBerry, Palm
Pilot); Smartphones (e.g., iPhone); enterprise digital assistants (EDA); portable media players
(i.e., MP3-players and MP4-players, e.g., iPod); handheld video-game consoles (e.g., PlayStation
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Portable (PSP), Nintendo DS); and handheld and ultra-portable computers such as tablet PCs
(e.g., iPad and Smartbooks)” (Free et al., 2013, p. 2).
Mhealth technology has been adopted in several areas of healthcare, including but not
limited to adherence to medication (Park, Howie-Esquivel, Chung, & Dracup, 2014), disease
prevention (Cole-Lewis & Kershaw, 2010), appointment reminders (Prasad & Anand, 2012),
data collection (Tomlinson et al., 2009), and diagnosis of diseases (Breslauer, Maamari, Switz,
Lam, & Fletcher, 2009). Figure 1 shows some of the applications of mhealth technology in
healthcare.

Figure 1 Applications of mhealth technology (Kumar et al., 2013)
Most of the mhealth implementations were carried out in developed countries. However, in
developing countries where healthcare systems lack the resources and efficiency to provide highquality services, patients, and the community, the adoption of mhealth has not been widely
explored. Therefore, this study aimed to enhance the quality of healthcare services for diabetes
and hypertension patients with mobile health technology in Saudi Arabia.
2

1.2

Significance of Research

Chronic diseases patients such as hypertension and diabetes are susceptible to some health
complications if they failed to manage their diseases regularly. This situation is more prominent
in developing countries where limited resources are available, and access to healthcare services
is very challenging. Therefore, encouraging diabetic and hypertensive patients to manage their
diseases and adhere to medications are very crucial. This can be accomplished, for instance,
using mhealth technology.
This study aims to enhance the effectiveness of mhealth platforms in developing nations for
diabetes and hypertension diseases. This goal is achieved by redesigning a mobile application
that fits the requirements of diabetic and hypertensive patients and used the blood sugar level test
(Hemoglobin A1c). The proposed mobile application is intended to perform two tasks, which
are: managing patients’ adherence to medication refill timing and managing patients reminders
of physicians' appointments. The blood sugar level test will help to manage the number of
unnecessary follow-up appointments. Based on the results, patients who show improved or stable
health conditions may be temporarily dismissed from the follow-up appointments’ list, which
will allow the healthcare center to provide health services to more patients with a given time
frame.
Accordingly, the developed mobile phone application and the blood sugar level test will
improve access to health care services through decreasing the physical contact between patients
and healthcare workers and investing the saved clinic-time to serve new patients. It will also lead
to improving healthcare service cost-effectiveness for both healthcare providers and patients,
which will positively impact the developing nations' economy. Finally, the developed mobile
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application will assist in encouraging diabetic and hypertensive patients to manage their diseases
and adhere to medications and doctor appointments.
1.3

Theoretical Foundation of Work

Many studies have investigated the factors that may contribute to adherence to
medications of patients with chronic diseases such as diabetes and hypertension. In one study,
the influence of health beliefs on medication adherence among patients with type 2 diabetes was
investigated (Alatawi, Kavookjian, Ekong, & Alrayees, 2016). The Health Belief Model (HBM)
was used in this study to explore the medication-taking behavior of diabetic patients in Tabuk,
Saudi Arabia. A convenience sample of size 217 diabetic patients of both genders and were over
18 years old were included in the study. A questionnaire containing demographic, medical
history, medication adherence, and health beliefs information regarding diabetes was used in this
study. The results revealed that almost 43% of the participants did not comply with their
medication for at least one day in the past week.
In another study, adherence of patients with type 2 diabetes to the standards set by the
American Diabetes Association (ADA) was investigated in the city of Riyadh, Saudi Arabia (Al
Harbi et al., 2015). In specific, adherence of diabetic patients to 11 ADA standards, including
glycemic control, blood pressure control, and lipid management, were studied. A sample of 450
diabetic patients, who were at least 18 years old, and who visited the health center more than
once during six months, was selected to participate in the study. The results showed that the
majority of the patients were between 50 and 69, with less than half of which being male. Also,
about 85% of the patients were either overweight or obese. The results also showed that
compliance with the ADA standards ranged from 35.6% for Nephropathy screening to 92.9% for
Blood pressure measurement.
4

The effects of some socio-demographic factors on the compliance to the medication of
diabetic patients have also been investigated in Abha, Saudi Arabia (Salam & Siddiqui, 2013). A
total of 406 patients with type 2 diabetes were randomly selected to participate in the study. The
data were collected from the participants through a questionnaire, which included items on diet,
exercise, medication, and follow up. The results showed that patients who were 40 years or
younger showed significantly higher levels of adherence to appointment and diet compared to
older patients. On the other hand, older patients showed significantly higher levels of compliance
with medication. Moreover, the study also reported that most of the patients were compliant
with medication and follow up regardless of their personal characteristics.
Similarly, a study examined the factors that may have potential effects on the level of
non-compliance of diabetic patients in three chronic disease clinics in Al Hasa, Saudi Arabia (A.
R. Khan et al., 2012). The study used a survey to measure the non-compliance of a total of 353
randomly selected patients with diabetes, 468 of which completed the study. The questionnaire
included demographic items such as gender, age, marital status, and level of education. It also
included other medical items such as the presence of other chronic diseases, the number of
medications taken, the frequency of taking medication, and the frequency of follow up visits.
The results revealed that the overall non-compliance rate was found to be 67.9%, with male
patients have significantly higher non-compliance rates than female patients. Also, the noncompliance rate of patients taking oral and insulin treatment was found to be more than 79%,
while the patients taking only one medication showed a non-compliance rate of 48%.
In the same context, medication adherence among patients with chronic diseases visiting
an outpatient clinic in Riyadh, Saudi Arabia, was also evaluated (Tourkmani et al., 2012). The
study evaluated the potential relationship between motivation and knowledge on the intention to
5

comply with the medication of chronic diseases such as diabetes and hypertension. A
questionnaire was used, and a sample of 347 patients was included in the study. The
questionnaire was designed to elicit specific information for the participants including
demographic characteristics, medical history, and medication history. The results noted that more
than 75% of the participants had at least two chronic diseases and taking on average more than
six medications. The results also reported that more than 58% of the participants had a high rate
of intention to comply with medication. Furthermore, the study reported that no relationship
between motivation and knowledge of medication regarding adherence to medication was found.
Moreover, a review was conducted on patients’ adherence to medications of chronic
diseases, such as hypertension, in the middle eastern countries, including Saudi Arabia (Al
Qasem, Smith, & Clifford, 2011). The study reported that patients’ self-reporting, pill counts,
and blood pressure measurements were used to determine the adherence to the medication of
hypertensive patients. The study also reported the reasons for patients’ nonadherence to
medication and indicated that the nonadherence rate of patients with high blood pressure was
higher than those with diabetes. Thus, there is a need to adopt a healthcare intervention such as
mhealth to promote self-management for patients with hypertension to reduce the rate of
nonadherence to medication that is reported in the literature.
In another study, the factors that may influence the compliance diet, medication, and
appointments of patients with diabetes have been explored in Abha, Saudi Arabia (Khattab,
1999). A total of 294 diabetic patients were involved in the study. The compliance was measured
based on the number of visits of diabetic patients during a 6-month period. In specific, patients
who visited the health center at least one-two occasions during six months were considered to
have good compliance. Also, patients who visited the health center on one occasion during the
6

six months were classified to have poor compliance. In addition, poor compliance was defined as
the patients who failed to visit the health center during the six-month period. The results revealed
that more than 61% of the participants were good compliant with appointments. Regarding
compliance with drugs, the majority (84.2%) of the participants showed good compliance, while
less than 2% showed poor compliance. The study also reported a significant difference between
males and females in terms of good compliance, with male patients being more compliant than
female patients.
In addition, to identifying the factors influencing patients’ adherence to medication, other
studies were exploring the reasons that led patients to miss prescheduled appointments. For
example, the reasons for missing appointments were investigated in a military hospital in
Riyadh, Saudi Arabia (Alhamad, 2013a). The study included two groups of randomly selected
patients for each sample of 380. The first group included the patients who missed their
appointments, and the second group was set to be the control group, which included the patients
who showed up for their appointments. The study defined the missing appointments as either the
patients who didn’t attend at least one prescheduled with the clinic or the patients who showed
up later than their prescheduled appointment time. The results indicated that the difficulty in
booking an appointment, long-distance travel, work commitment, lack of transportation, and
visiting another hospital were the most frequently reported factors that contributed to missing
appointments. Moreover, no significant difference between the experimental group and the
control group in regard to the reasons cited for missing appointments.
The use of mhealth interventions may promote medication adherence and hence improve
healthcare service delivery for patients with chronic diseases. However, the acceptability of such
interventions should be evaluated prior to their implementation to ensure feasible results. In fact,
7

Alkhudairi evaluated the acceptability of a mobile phone diabetes management application by
diabetes specialists in Saudi Arabia (Alkhudairi, 2016). Specifically, the study examined whether
the use of mhealth applications would improve the management of diabetes. The study examined
the feasibility and challenges of using a mobile phone application called Glucose Buddy within
the context of Saudi Arabia through conducting interviews and questionnaires of selected
participants and medical professionals. The study indicated that mobile phone applications such
as Glucose Buddy could be successfully implemented within the Saudi context giving
appropriate training and incentives.
Electronic health record (EHR) applications have also been used to improve healthcare
service delivery in three public hospitals in eastern Saudi Arabia (El Mahalli, 2015). Specifically,
the study evaluated the barriers using HER by physicians as well as its utilization. The study
used a self-administered survey to gather data from a total of 555 physicians, 357 of which who
completed the questionnaire giving an average response rate of nearly 56%. The questionnaire
contained items of demographic information, the functionality of HER, and barriers to use HER.
The results showed that most of the respondents had access to a computer at work. For chart
review, the study showed the highest frequency of utilization was found to ‘Obtain and review
lab results’ (94.4%). However, the study also reported a lack of utilization of communication
tools such as email and SMS text messaging. Regarding the barriers to use HER, the study
reported that ‘system hanging up problem’ and ‘loss of entree to medical records transiently if
the computer crashes or power fails’ were the two most cited barriers.
Some studies evaluated the effectiveness of mobile health applications in Saudi Arabia.
In one study, a randomized control trial was conducted over a six-month period to evaluate the
effectiveness of SAED to manage and educate diabetic patients in Tabuk, Saudi Arabia
8

(Alotaibi, Istepanian, & Philip, 2016). A total of 20 patients aged from 20 to 65 years were
aimlessly nominated to contribute to the study, and they were separated into two groups, with ten
patients allocated to the nonintervention group and ten patients allocated to the intervention
group. Patients’ information, such as blood glucose levels were recorded two to three times a day
on two to three different days a week. Moreover, patients in the control group received weekly
SMS text messages to promote their knowledge of diabetes and related risk factors. To measure
the effectiveness of SAED, patients’ Hemoglobin levels, as well as a test of knowledge about
diabetes, were used before and after the intervention. The results revealed a significant reduction
in hemoglobin levels of patients in the intervention group compared to the control group.
Furthermore, patients’ knowledge about diabetes was higher in the intervention group comparing
to the control group, although both groups showed a significant improvement in their knowledge
before and after the intervention.
In another study, Abbas and his colleagues evaluated the effectiveness of using SMS text
messaging to control glycemic of diabetes patients within Riyadh (B. B. Abbas, Al Fares,
Jabbari, El Dali, & Al Orifi, 2015). A sum of 100 patients with diabetes type 2 was chosen to
participate in the study. Variables such as glycosylated hemoglobin (HbA1c), blood glucose
levels, and average fasting blood sugar were assessed before and after the SMS intervention.
During the intervention, patients received from five to seven messages every week, including
educational information about diabetic care and management in the Arabic language. The text
messages were also designed to remind patients of taking their medications and checking their
blood glucose levels. The results indicated that a significant decline in patients’ blood glucose
levels and average HbA1c. The study also reported a significant improvement in patients’
knowledge of diabetes.
9

Based on the studies discussed above, there is a lack in the literature regarding the
effectiveness of the use of the mobile health platform to provide services such as medication
refill reminders, doctor appointment reminders, and managing unnecessary follow-up visits of
patients with diabetes and hypertension in developing nations. Although some investigation
studies have been conducted about diabetes in Saudi Arabia, no research studies in literature
investigated the use of mhealth technology for hypertension disease management in the country.
Designing a mobile phone application with such features may help patients better manage their
diseases and promote their adherence to medication. This also results in limiting the prevalence
of chronic diseases, such as diabetes and hypertension in Saudi Arabia. This study, therefore,
aims to fill this gap by developing a mobile phone application that aims to help diabetic and
hypertensive patients manage their diseases in Saudi Arabia. Also, the developed application
provides other services such as doctor appointment reminders and medication refill reminders.
1.4

Research Question

Q1: Does utilizing of refill medication reminder feature of DHA Tracking has a positive
statistically significant impact on medication adherence levels of diabetic and hypertension
patients in developing countries?
Q2: Does utilizing the pre-appointment checkup feature for Hemoglobin A1c tests have a
positive statistically significant impact on decreasing the number of visits per patient for diabetic
patients in developing countries?
Q3: Does utilizing doctor appointment reminder feature of DHA Tracking has a positive
statistically significant impact on adherence to doctor appointments of diabetic and hypertension
patients in developing countries?
10

1.5

Contribution to the Body of Knowledge

The aim of adopting mhealth technology in developing countries is to increase the
effectiveness of healthcare systems and enhance the quality of healthcare services, which will
eventually increase customers patients’ satisfaction. However, there was a lack of evidence
regarding the evaluation of the effectiveness of mhealth technology in developing countries. In
Saudi Arabia, the majority of mhealth interventions were either pilot projects or qualitative
survey design studies with small-scale settings. This represents a gap in the literature regarding
the implementation of mhealth technology in Saudi Arabia. This study, therefore, contributes to
the current body of knowledge through enriching the body knowledge related to the mhealth
platform use in Saudi Arabia. The study will also help in facilitating health care services by
advancing the self-management of diabetes and hypertension diseases.
Also, studies that examined the feasibility of using mobile phone applications to provide
healthcare services to diabetic and hypertensive patients in Saudi Arabia focused on disease
prevention (Tate et al., 2013) and medication adherence (Alotaibi, 2015). However, no studies
have been conducted to provide managing information to patients with hypertension in Saudi
Arabia. Thus, this study contributes to the body of knowledge by being the first study in Saudi
Arabia that provides managing information to healthcare providers using a mobile health
application.
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CHAPTER TWO: LITERATURE REVIEW
2.1

Information and Communication Technology and mobile health in Saudi Arabia

Saudi Arabia is a country that could make use of today’s focus on technology.
Information technology, otherwise known as IT, is growing rapidly and influencing all of its
economy (Alshuaibi, 2017). The kingdom wants to diversify its economy rather than relying on
oil, and it also desires to fulfill its people’s needs to have jobs and careers. IT is the way to do
that, and for the Saudi kingdom, it makes sense. They still have oil as a significant contributor to
their economy and can use that money to enter the field of IT strongly in the near future. In fact,
it intends to do so in its vision of 2030 (Alshuaibi, 2017).
If the Kingdom wishes to complete its goals in vision 2030, it will have to invest in
technology, especially in healthcare. Saudi Arabia wants to be the leader of the nations around it,
but without a focus on healthcare may not be able to accomplish that goal. The health industry
needs information technology. Electronic health records (EHR) is a good software that could be
utilized. It reduces paperwork in hospitals, and that means it allows for a patient's records to be
found quickly. Doctors can interact with one another and records can be given to a variety of
parties that need its information.
Saudi Arabia has started the process of investing in Information and Communication
Technology (ICT). The kingdom has adopted ICT as one of its major investments, which it is
using to create a more diverse economy that will allow it to continue to grow its economy and
get to the place where it can have economic growth that is more sustainable (Al-Maliki, 2013).
However, the situation is not perfect. Some problems must be addressed if they are going to
become a serious competitor with other countries that are investing in ICT. In the past, the
12

kingdom has been forced to allow its young people to go to other countries in order to get an
education at all and particularly education in ICT (Al-Maliki, 2013). It has been making efforts
to increase the skilled labor within its society, but foreigners are still often the ones that take the
jobs where they can be found.
On the other hand, Saudi Arabia is doing well in that it has the largest IT market in the
region (Al-Maliki, 2013). It is trying to focus on the home market as well and has had a series of
five-year plans to approach that goal and others. Some of its other efforts include that it has been
either increasing or upgrading the schools in the area of science and technology. This starts at the
lower grades and goes on through the entire system. It is also educating its people on the fact that
sciences and technology play a role around the world and have tried to accomplish these tasks
through the media, exhibitions, and symposiums (Al-Maliki, 2013).
Unfortunately, the kingdom has not accomplished enough and still faces some barriers.
While it does have an infrastructure superior to that of its near neighbors, it does not have one
that is equal to that of fully developed countries (Al-Maliki, 2013). While it wants to sell its
products to its people, it has a simple (or complicated) problem that its people are not very
familiar with computers, and it does not protect the rights of intellectual property. It also does not
have the infrastructure to support the industry, and so it has some work to be done shortly. The
kingdom must move forward in ICT in the future because other kingdoms and countries, even in
its area, are working toward the same goal.
There are some definite improvements in Saudi Arabia’s ICT situation. According to
Abdulgahni, Ahmad, & Salah (2014), there is an improvement in the areas of growth of prepaid
and postpaid mobile phones, Internet and fixed wireless facilities, as well as current investment
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in ICT. The mobile industry has done well in this regard. The following table 1 supports that
view:
Table 1 T-test on Mobile Service Market Growth Subscription (2001- 2013) (Abdulgahni,
Ahmad, Salah, & Abdulghani, 2014)
Users

Mean (S+D)

P

*Post-Paid Subscription

5.06 + 1.54

0.00

*Pre-Paid subscription

23.86 + 18.77

0.001

Total subscription

28.93 + 20.26

0.000

** Mobile penetration

107.20 + 68.47

0.000

The above table shows that there is penetration and increasing subscriptions, although prepaid
subscriptions appear to be preferred.
There have also been increases in other Internet and mobile situations, but the authors do
admit that more work is needed in this area. They conclude that the kingdom’s businesses could
benefit from using ICT networks as this would aid in breaking down barriers to go into new
markets (Abdulgahni et al., 2014). While progress is being made, there is more that has been left
undone.
The major concern and need for good technological devices in Saudi Arabia as in other
countries is the need for better health care. The kingdom has advanced in technology in general
but lags behind other nations in terms of technology used for health care. The advances in
technology have neglected the healthcare industry, while other industries have benefited from its
use (ALSADAN et al., 2015). These researchers have investigated this situation using articles in
various journals that were published between 2001 and 2014 (ALSADAN et al., 2015). The
review of these sources had predetermined requirements included “conceptual, exploratory, and
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cross-sectional and action research. Of the over 600 studies, 29 were selected for this review.
They found that most Arab countries had the money to pursue the Health Information
Technology (HIT) but did not pursue research or implementation of mHealth and suffered from
the problem that they did not have the knowledge to pursue the use of HIT. The use of this
technology is important to the development of hospitals and other institutions. They are not
ready to compete with developed countries and the need for that possibility is great.
Telemedicine is rampant in fully developed countries, but in Saudi Arabia, physicians
often do not use such techniques, and the reasons are not necessarily that they do not want to.
Research has shown that most physicians in Saudi Arabia are well aware of telemedicine and are
open to using it. There is some practice of telemedicine in Saudi Arabia, but it is spread out, and
not everyone has access to it (Alajmi et al., 2015). However, the degree to which physicians have
good awareness and positive attitude telemedicine depend on age. Older physicians know less
about it and are less accepting of it (Alajmi et al., 2015). Those who had more experience with
technology in medicine were eager to get involved in its use and to learn about it. This author
suggests that the target for change includes older physicians and those who are open to change
and training.
Mobile phones are used in Saudi Arabia by medical residents. Jamal et al. (2016)
researched the degree of usage of mobile phones using a cross-sectional survey that was webbased. The researcher found that almost all residents used mobile phones within and outside of
their medical practice. While they used them in practice, they did not always know the degree to
which they could use them with proper training. This suggests that there is a need for
encouraging and training medical residents to use the phones fully rather than just for
communication (Jamal et al., 2016). Smartphones can be particularly useful in the medical field,
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as they have more possible uses than cell phones. Smartphones can be used for appointment
reservations, opening and updating medical records, communication with patients and
consultation, doctor’s directory, requesting medical reports and assessing the health risk for
patients (Saad, 2016). The researcher undertook to decide whether or not these extra uses would
be necessary and essential for patients since they are the true end-user. If they are useful, the
researcher wants to know to what degree they are useful. They point out that using these phones
can be helpful, but they are also expensive. This research has not yet been completed.
2.2

Healthcare System in Saudi Arabia

In the 1950s, Saudi Arabia had witnessed the first organized preventive health services
through the campaign that was launched by the Saudi Ministry of Health (MOH), the World
Health Organization (WHO), and the Saudi Aramco oil company against malaria in Al Ahsa
Oasis and Qatif in the Eastern province of Saudi Arabia (Al Yousuf, Akerele, & Al Mazrou,
2002). Other provinces in the county started similar malaria control programs right after the
success of the control program in this province. Afterward, the development of the Saudi health
system evolved slowly until the middle of the 1960s, where rapid expansion of the system took
place between 1965 and 1985. The healthcare service offered between 1970 and 1980 were
curative due to both the nature of health personnel training programs, which was conducted in
patient-oriented, hospital-based medical institutes, and general population expectation about the
type of healthcare services they consider useful (Al Yousuf et al., 2002). In the 1980s, primary
health care centers (PHC) were established where existing health offices, maternal child and
health centers, and dispensaries were integrated administratively (Al Yousuf et al., 2002). By
initiating the PHC approach, the delivery of integrated healthcare services was developed (Al
Yousuf et al., 2002). The health system of Saudi Arabia is a three-tier system composing of
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primary, secondary, and tertiary layers of healthcare providers (Al Yousuf et al., 2002; Alanazy,
2006). Respectively, these layers are the healthcare centers, the general hospitals, and the
specialized hospitals (Al Yousuf et al., 2002). There are three healthcare sectors of which Saudi
health system is composed: the MOH, the non-MOH government healthcare providers (i.e., the
Ministry of Interior, Ministry of Defense, the National Guard, universities, and King Faisal
Specialist Hospital), and the private healthcare sector (Al Yousuf et al., 2002; Alanazy, 2006).
The PHC’s represent an important component of the Saudi Health System since they are the first
point of contact for the patient with the entire national system (Al Yousuf et al., 2002). Out of
the 191 countries that were included in the 1997 estimates of WHO for the quality of healthcare
services, the Saudi health system was ranked 26th worldwide and 2nd among Arab countries (Al
Yousuf et al., 2002).
The responsibility of providing preventive and curative healthcare services in Saudi
Arabia is primarily administered by the MOH, which assures the offering of these services to all
Saudi populations as free services (Alanazy, 2006). Also, King Faisal Specialist Hospital and
Research Center (KFSH & RC) and Universities’ hospitals receive complex cases that require
special intervention besides their significant role in conducting research in the healthcare area
and providing educational and training programs for the medical staff of the country (Alanazy,
2006). Healthcare Services of the non-MOH government hospitals are limited to the workers of
the government sector, offering these services and their dependence (Alanazy, 2006). However,
like the case with KFSH & RC and universities’ hospitals, the general population can access the
services of these sectors, through a referral mechanism, should the patient condition require
special treatment available only at one of these non-MOH government healthcare institutes
(Alanazy, 2006). Other than governmental healthcare providers, there are private healthcare
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providers all over the country which, in 2015, covered around 36.7% of total patients and 35.5%
of total inpatients of Saudi population (M. o. H. General Directorate of Statistics and
Information, Kingdom of Saudi Arabia, 2017).
Healthcare services in Saudi Arabia have been significantly developed in several areas
related to preventive, curative, antenatal, and childhood care services (M. o. H. General
Directorate of Statistics and Information, Kingdom of Saudi Arabia, 2017). For instance, over
the last two decades, mortality rates in children under the age of five decreased from 85 to 8.05
per 1000 live births, infant mortality rate was reduced from 76 to 2.74 per 1000 live births, and
the total life expectancy at birth increased from 61 to 71.9 (M. o. H. General Directorate of
Statistics and Information, Kingdom of Saudi Arabia, 2017). These indicators are higher than
those achieved by other developing and Arabic countries and reflect the significant improvement
in the amount and types of healthcare services provided by healthcare institutes to the entire
population (M. o. H. General Directorate of Statistics and Information, Kingdom of Saudi
Arabia, 2017). Tables 2 and 3 below provide more indicators about the Saudi healthcare system
as per the Health Statistics Book of MOH in the Kingdom of Saudi Arabia, which was lastly
updated in 2017.
Table 2 Immunization Coverage with primary health care services (2016)
(General Directorate of Statistics and Information, 2017)
Indicator

Year

Hexa. Vaccine

98.5

2016

Oral Polio Vaccine (OPV)

98.5

2016

BCG Vaccine

98.5

2016

MMR Vaccine

98

2016

Pneumococcal Conjugate Vaccine (PCV)

98.7

2016
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Table 3 Health status indicators (General Directorate of Statistics and Information, 2017)
Total life expectancy at birth (years)

74.8

2016

Male life expectancy at birth (years)

73.5

2016

Female life expectancy at birth (years)

76.1

2016

The Crude Death rate per 1000 population

2.9

2016

Newborn with low birth weight (%)

8.96

2016

Neonatal mortality rate per 1000 total birth

2.74

2016

Infant mortality rate (per 1000live births)

4.82

2016

Under-five mortality rate (per 1000live births)

8.05

2016

Maternal mortality rate (per 100000 live births)

12

2015

In the 1970s, some physicians and nurses working in different Saudi health institutes
were 1172 and 3261, respectively (Ministry of Economy and Planning, 2004). In 2017, the Saudi
healthcare sector had 470 hospitals with 70,844 beds, 89,675 physicians, and 107,323 nurses all
over the thirteen provinces of the country (M. o. H. General Directorate of Statistics and
Information, Kingdom of Saudi Arabia, 2017). Table 4 below presents the distribution of the
total number of hospitals, beds, and physicians, in 2017, over the three main sectors of the Saudi
healthcare system. In addition, Table 5 presents the rate of Saudi healthcare human and physical
resources per 10,000 populations as per the statistical book of Ministry of Health in 2017.
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Table 4 Hospitals, beds & physicians’ distribution over main sectors of the Saudi healthcare
system (2017) (General Directorate of Statistics and Information, 2017)
Sector

Number of Hospital
(%)

Number of Beds (%)

Number of Physicians
(%)

Ministry of Health
(MOH)

274 (58.29)

41835 (59.05)

42768(47.69)

Other Government
Health Services

44(9.36)

11581(16.34)

17206(19.18)

Privet Hospital

152(32.34)

17428(24.6)

29701(33.12)

Total

470

70844

89675

Table 5 Human and physical resources indicators (Rate (R) per 10,000 populations) (General
Directorate of Statistics and Information, 2017)
Physicians

28.3

Dentists

4.4

Pharmacists

7.9

Nursing

57

Hospital beds

22.3

Primary Health Care Centers - MoH

0.7

Despite the progress in healthcare services provided by various sectors of the Saudi
healthcare system, the system is challenged with the continuous improvement of the financial,
physical, and human resources involved in providing these services so that they could be offered
to all people at all time (M. o. H. General Directorate of Statistics and Information, Kingdom of
Saudi Arabia, 2017). Table 6 below presents the annual MOH budget between 2012 and 2016
(M. o. H. General Directorate of Statistics and Information, Kingdom of Saudi Arabia, 2017),
although this budget is consistently falling between 6.6 and 7.25 of the total budget of the
government.
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Table 6 MOH annual budget from 2012 – 2016 (General Directorate of Statistics and
Information, 2017)
Year

GOVERNMENT BUDGET

MOH Budget

(%)

(Billion SAR)

(Billion SAR)

2012

690

47.076

6.80%

2013

820

54.350

6.63%

2014

855

59.985

7.02%

2015

860

62.342

7.25%

2016

840

58.899

7.01%

Nonetheless, Saudi population healthcare demand is expected to the further increase over the
coming decades as a result of the following factors (M. o. H. General Directorate of Statistics
and Information, Kingdom of Saudi Arabia, 2017):
•

The high growth rate of the Saudi population is expected to continue increasing
until 2024. In 2016, the Saudi population reached 31.7 million out of which 11.6
million (63.4%) are citizens with a 2.54% average growth rate based on Health
Statistics Book of MOH 2017. Because of this high growth rate, compared to
2.1% for other Arabic countries and 1.5% for developing countries, 65.46% of the
Saudi population is between the age of 15-64 while 4.17% is over 65 years. Table
7 below presents some of the above-stated data as per the Health Statistics Book
of MOH in 2017.
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Table 7 Saudi demographic indicators (2017) (General Directorate of Statistics and Information,
2017)

•

The area in a square kilometer

2,000,000

The total population of thousand

31,742

% Urban population out of a total population

63.4

Crude birth rate /1000 population

17.23

Crude Death rate /1000 population

2.9

% Population Growth Rate

2.54

% Population Under 15 years

30.35

% Population between15- 64 years

65.46

% Population from 65 & above

4.17

Total fertility rate

2.4

The Saudi population has developed awareness about the importance of
healthcare aspects, especially the preventive-based ones. For instance, a 2017
survey showed a decrease in the rate of German Measles due to high coverage of
immunization and the completion of the first stage of the comprehensive
Vaccination program for students in middle and high school. Also, the survey
showed there was no case recorded of poliomyelitis. Also, the immunization rate
of infants by three doses of pertussis, diphtheria, tetanus, anthrax, hemorrhagic
influenza, hepatitis B, and poliomyelitis was 98.5% in 2016.

•

The Saudi population's life expectancy at birth has increased from 53 years in the
1970s to 73.5 years for males and 76.1 for females in 2016.

•

The change in the nature of diseases.

•

The change in the Saudi population lifestyles.

As a step to fulfill the increasing demand, the Council of Cooperative Health Insurance
(CCHI) was established in 1999 to enforce insurance-based health care services for workers in
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private business organizations (Council of Cooperative Health insurance, 2016). By the year
2002, CCHI's responsibilities were expanded to cover the enforcement of providing healthcare
services to all Saudi populations on insurance-based schemes. Some of the CCHI tasks include
(Council of Cooperative Health insurance, 2016):
•

Providing an integrated healthcare services network that covers the whole
country.

•

Expanding the decentralization of health services management so that each
health affair in the thirteen Saudi provinces is given administrative and financial
authority enough to handle its duties more effectively.

•

Studying the feasibility of privatizing some of MOH hospitals.

•

Providing policies and regulations that assure effective operation of MOH and
other government hospitals based on economic and quality considerations.

Table 8 Saudi health expenditure indicators (2015) (World Health Organization, 2015)
Total expenditure on health (per capita) US$ exchange rate

807.8

Government expenditure on health (per capita) US$ exchange rate

518.8

Total expenditure on health % of GDP

3.2

General Government expenditure on health as % of total health expenditure

64.2

Out of pocket expenditure as % of total health expenditure

19.8

However, obligations of providing insurance-based healthcare services are still limited to
workers of private business organizations, while the remaining population healthcare needs are
covered either by MOH and other government hospitals or through private hospitals on the outof-pocket basis (Ministry of Economy and Planning, 2004). As per Regional Office of World
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Health Organization for the Eastern Mediterranean website which was lastly updated in 2015,
Table 8 above shows 64.2% of Saudi’s total health expenditure in 2015 was provided by the
government while only 19.8% of the total expenditure was out-of-pocket (World Health
Organization, 2015).
Based on these figures, most of the Saudi population's health needs are still provided by
the government for free. Therefore, the Department of Statistics and Information in the Ministry
of Health in Saudi Arabia in 2017 included the following objectives to cover the increasing
healthcare needs of Saudi population (Ministry of Economy and Planning, 2014):
•

Reduce the proportion of births below normal weight to less than 5% and improve health
and nutrition indicators for children under five years of age;

•

Opening new 400 ambulance centers and Securing 25 ambulances and providing 1,500
ambulances in the Saudi Red Crescent plan;

•

Expanding the insurance-based healthcare services;

•

Determining the number of government hospitals which are going to be privatized;

•

Upgrading the healthcare current management information network;

•

Delivery within health institutions should be at least 98%;

•

Reviewing the current organizational structures and developing new ones;

•

Providing new rules and regulations for operating the governmental hospitals on an
economic basis;

•

Reviewing the current regulations and policies that govern and audit the quality of
service;

•

Achieving integrated connectivity among governmental hospitals and primary healthcare
centers;
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•

Opening new health Science colleges and renovating 22 of the existing ones;

•

Expanding the use of digital and wireless communication systems in order to improve
current response rates.

•

Opening 750 new primary healthcare centers.

•

Establish, produce, and operating public and specialized hospitals with 37,000 beds
(Ministry of Economy and Planning, 2014).
2.3

Diabetes and Hypertension and Related Diseases

Diabetes is a serious disease that consists of two different types. Type 1 Diabetes is not as
common as type 2 is. However, it is identified as the absolute lack of secretion of insulin from
the body’s pancreas. Without insulin, the body is not able to correctly deal with sugars in the
human cells. The second type is type 2, which is far more common than type 1 (American
Diabetes Association, 2010). “Type 2 diabetes ranges from predominantly insulin resistance with
relative insulin deficiency to predominantly an insulin secretory defect with insulin resistance”
(American Diabetes Association, 2010, p. 563). Diabetes of any kind has an impact on those
with this disease. Since there is a resistance to insulin, one of the impacts on the body is due to
the fact that the amount of sugar in the blood increases because the sugar is not being used for
the good of the cells and the extra sugar leads to other illnesses, making it important that this
disease, if it cannot be eliminated can at least deal with the problem of the extra sugar (American
Diabetes Association, 2010).
In Saudi Arabia, there are large numbers of adults who are at risk of suffering from heart
problems with type 2 diabetes. In 2015, Al Slail investigated the risk profiles of adults for
developing cardiovascular risk. They took data from the hospital records for 422 patients in
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different diabetes clinics in Riyadh. Their motivation was to discover the number of type 2
diabetes patients seen at facilities, what type of patients were meeting the American Diabetes
Association's suggested levels and what conventions were associated with accomplishment best
control of coronary illness hazard factors (Al Slail, Abid, Assiri, Memish, & Ali, 2016). The
scientists found that 70% of the patients had at least two hazard factors for cardiovascular
sickness, and a major extent was not controlling those dangers. There is, therefore, an urgent
need to educate these people and encourage them to guard their health.
These researchers also investigated hypertension along with cardiovascular risks. They
found that 12% of the patients surveyed had reasonable blood pressure measurements. Al Slail
found that the results for blood pressure problems in 2010 were lower, which suggests that there
is also a need for educating patients and encouraging them to take blood pressure conditions
seriously and adhere to the rules for their disease (Al Slail et al., 2016).
Hypertension is a problem in Saudi Arabia. Researchers such as Al-Tuwijri & Al-Rukban
(2006) have investigated this problem. They conducted a cross-sectional study reviewing
medical records of over 200 hypertensive patients. These were people being treated at miniclinics in Saudi Arabia. The nurses at these mini-clinics collected the data developed for the
study. The goal of the study was to find out how much control of blood pressure and how many
common co-morbidities existed among these hypertensive patients. After the study was
completed, the researchers discovered that there is poor blood pressure control in the miniclinics. They recommended that there should be better physician knowledge and better attitudes
toward the reality that blood pressure levels must be kept in a reasonable state in order to prevent
further problems for the patients, including the possibility of early death (Al-Tuwijri & AlRukban, 2006).
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Although diabetes types 1 and 2 are the main types of diabetes that are found in the
world, there is a third type of diabetes, the “Gestational Diabetes Mellitus type.” In 2006, Carr
research team investigated whether gestational diabetes makes it more likely that a woman with a
history of type 2 diabetes is in more serious danger of having cardiovascular disease. This study
investigated 332 women who either did or did not have a family history of (GDM). This study
included women who were mostly middle-aged and were obese. Those with earlier GDM were
more youthful and more probable than the other ladies to be African American. Race/ethnicity
was viewed as a potential confounder for the outcomes and was incorporated into the balanced
examination (Carr et al., 2006).
Obesity is frequently joined by diabetes, and keeping in mind that the two gatherings
were fat, those in the GDM aggregate had higher fasting glucose and insulin levels. Those were
more insulin safe. The researchers found that CVD was thoughtfully more typical in ladies with
GDM race/ethnicity, age, and menopausal status did not change the connection amongst GDM
and cardiovascular disease (Carr et al., 2006).
2.3.1

Diabetes type 2 and Hypertension in Saudi Arabia

Diabetes is one of the Noncommunicable Diseases (NCD) that affected a myriad number
of people around the globe. The number of people diagnosed with diabetes has dramatically
increased in recent years. According to International Diabetes Federation (IDF), the assessed
number of diabetes patients in 2017 is 424.9 million, with an expected growth of nearly 48%,
reaching 628.6 million in 2045 (International Diabetes Federation, 2017). Moreover, the number
of deaths because of diabetes, according to the same report, is estimated to be four million in
2017.
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Saudi Arabia is among the countries that have the highest number of people with diabetes
in the middle east, with 17.7% of the country’s population having diabetes (International
Diabetes Federation, 2017). Several studies evaluated the prevalence of diabetes in Saudi Arabia
and its associated risk factors. Al-Daghri conducted a questionnaire to assess the presence of
some of the chronic diseases, including type 2 diabetes, in Riyadh, Saudi Arabia (Al-Daghri et
al., 2011). A total of 9,149 individuals aged from seven to eighty years were randomly recruited
in the study. The diagnosis of type 2 diabetes was based on the World Health Organization
(WHO) definitions. Patients’ glucose levels and body mass index were calculated. The results
revealed that the prevalence of type 2 diabetes was 23.1%. Also, it was found that the prevalence
of type 2 diabetes was significantly higher in males than in females.
Also, Ahmed conducted cross-sectional research to evaluate the prevalence of diabetes
among school children in Majmaah city in Riyadh Province, Saudi Arabia (Ahmed Syed Meraj,
2017). A total of 950 students (equally distributed between males and females) aged from seven
to fourteen were randomly selected to contribute to the study. Parents of the selected participants
were asked to fill out a semi-structured questionnaire containing information relevant
information about diabetes. The diagnosis process was carried out according to the WHO
guidelines. The results showed that 1.6% of the children had a body mass index above the
normal range.
The prevalence of diabetes in Saudi Arabia was reported to be significantly higher in
urban areas comparing to rural areas (Midhet, Al-Mohaimeed, & Sharaf, 2010). According to the
Saudi Health Information Survey for Non-Communicable Diseases in the Kingdom of Saudi
Arabia report (2013), there as a positive association between the prevalence of diabetes and the
age of the individual. The report revealed that the prevalence rate of diabetes among individuals
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aged from 15 to 24 was 4.7%, while the prevalence rate among individuals aged 65 and above
was 5.4%. Also, the prevalence of diabetes varied considerably among the different regions in
Saudi Arabia, with the lowest rate being in Jazan and the highest being in Ha’il. Figure 2 shows
the prevalence of diabetes in different geographical locations in the Kingdom of Saudi Arabia
(Saudi Health Information Survey, 2013).

Figure 2 Distribution of individuals with diabetes in Saudi Arabia (Saudi Health Information
Survey, 2013)
Individuals who have diabetes may develop other disease complications such as
retinopathy, kidney failure, myocardial infarction and stroke, and neuropathy (Klautzer, Becker,
& Mattke, 2014). Indeed, several factors associated with the high prevalence of diabetes,
especially type 2 diabetes (T2DM) in Saudi Arabia, have been reported. One of these factors is
the lack of physical activity, such as regular exercise. Figure 3 shows the level of daily exercises,
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defined as less than 10 minutes a day, in some countries in the middle east, including Saudi
Arabia (Klautzer et al., 2014). In addition to the lack of physical activity, poor nutrition was also
reported to have a considerable effect on the prevalence of diabetes in Saudi Arabia. Poor
nutrition was caused by the change in the dietary regimen of the populations in the Gulf
Cooperation Council (GCC) countries such as Saudi Arabia from consuming high protein, high
fiber food such as milk, fish, dates, whole wheat bread, and fresh vegetables to consuming food
that is high in saturated fats, refined carbohydrates, and low fiber (Badran & Laher, 2012).

Figure 3 Percentage of individuals with a low level of daily exercise in the middle east (Klautzer
et al., 2014)
In the same context, Medhet and his colleagues conducted a case-control study to identify
the factors that contribute to diabetes in six primary healthcare centers in Al-Qassim, Saudi
Arabia (Midhet et al., 2010). A sample of 283 individuals with type 2 diabetes was randomly
selected and used as the case group in the study. Also, a sample of 215 non-diabetic individuals
were randomly selected and used as the control group. The results revealed that regular
consumption of certain foods such as dates, bakery items, and full-fat dairy products
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significantly contributed to the prevalence of type 2 diabetes. Also, lack of physical activity,
especially those who live a sedentary life, had a greater risk of developing type 2 diabetes.
In addition to diabetes, high blood pressure or hypertension is also another NCD that has
been reported to have significant spread among human populations of the world. In fact, more
than 25% of the global population is diagnosed with hypertension (A. A. Saeed et al., 2011).
Also, the prevalence of hypertension is expected to increase by 24% in the industrialized
countries and up to 80% in the developing nations by 2025 (Kearney et al., 2005).
In Saudi Arabia, several studies estimated the prevalence of hypertension in Saudi Araba.
For instance, El-Hazmi and his colleagues conducted a study to estimate the prevalence of
hypertension in 35 regions in Saudi Arabia (El-Hazmi & Warsy, 1999). The study included a
total of 14,660 individuals from both genders. The study indicated that the prevalence of
hypertension was 4.37%. Also, significant differences in the prevalence of hypertension between
the regions were reported.
In another study, a national survey was designed to estimate the prevalence of
hypertension in all regions in Saudi Arabia (A. A. Saeed et al., 2011). A total of 4758 subjects
were randomly recruited to participate in the study. The survey included data regarding
demographic information, history of blood pressure, blood pressure measurements, and other
relevant factors. The study found that the frequency of total hypertension was 25.5%, and the
prevalence of blood pressure was higher in females.
According to the Health Information survey of Hypertension in the Kingdom of Saudi
Arabia (2013), the prevalence rate of hypertension was 17.8% among males and 16.5% among
females. The report also revealed that the prevalence of hypertension was higher (65%) among
individuals who are 65 and older, and it was varied across different geographical areas of the
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Kingdom. Figure 4 shows the prevalence of hypertension among different regions in Saudi
Arabia. Furthermore, the results of this survey indicated that the prevalence of hypertension was
positively correlated with obesity (26.4%) and diabetes (38.9%). To control the burden of
hypertension in Saudi Arabia, the ministry of health has initiated several health programs that
focused on the role of nutrition and physical activities promoting health and fighting chronic
diseases (Saudi Health Information Survey, 2013).

Figure 4 The prevalence of hypertension in different regions in Saudi Arabia (Saudi Health
Information Survey, 2013)
In a recent study, Saeed conducted a study to evaluate the prevalence of hypertension
among residents of Saudi Arabia (A. A. W. Saeed, 2017). A community-based survey containing
information about blood pressure and other relevant factors was conducted, and a total of 4588
individuals aged from 5 – 64 years were randomly selected from 20 regions and primary health
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care centers to participate in the study. The study indicated that the overall prevalence of
hypertension was 20.7%.
In addition to the assessment of the prevalence of hypertension in Saudi Arabia, some
studies investigated the potential risk factors associated with the prevalence of hypertension. For
example, a study conducted by Al-Hamdan and his colleagues to determine the factors affecting
hypertension found that there is an association between the development of hypertension and
age, gender, geographical location, education level, and employment status (Al-Hamdan, Saeed,
Kutbi, Choudhry, & Nooh, 2011). Also, the study indicated that lack of physical activity, body
weight, smoking, and diabetes significantly contributes to hypertension.
Hypertension is of great concern around the world. In 2014, a special communication was
suggested containing important guidelines for managing high blood pressure in adults.
Hypertension is dangerous and can lead to strokes, renal failure, and can even cause a person’s
death (Al-Hamdan et al., 2011). These researchers claim that there is heavy evidence that
supports treating high blood pressure at the age of 60 years or more with a hypertension goal
under 150/90 mm Hg and the hypertension person the age of 30 to 59 years to a diastolic goal of
under 90 mm Hg (Al-Hamdan et al., 2011). However, in each clinic, there may be differences,
and that should be respected, given they each human being is different, and physicians who have
treated the patient in the past might have different treatments of care.
Nevertheless, the researchers made certain recommendations and guidelines for people
with hypertension. The recommendations were based on rigorous research about hypertension
that was well backed up by science. They also took evidence from randomized controlled trials
that aided in determining both the efficacy and effectiveness of recommendations. The
recommendations indicated what should be done based on a person’s age (James, 2015). An
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older person needs different types of treatment than most younger people. There is also a
difference based on ethnic backgrounds. For example, people of color tend to be more
susceptible to hypertension than others. Therefore, in one case, they might suggest
pharmacologic treatment to lower the blood pressure to one patient and in another, the
recommendation might be antihypertensive treatment. Their recommendations differ from other
suggestions in previous literature.
Turner et al. (1998) investigated tight blood pressure control’s impacts on certain
harmful risks. These researchers noted that type 2 diabetes and hypertension are very related to
one another. They each provide increased risk for patients with cardiovascular and renal disease.
Their research included subjects with hypertension and some having type 2 diabetes. The
patients were between the ages of 25 and 65, and a total of 4297 subjects took part in this
research. The patients were divided into two different groups, and in one, there was right control,
and in the other, there were those under light control without drug treatment (UK Prospective
Diabetes Study Group, 1998). The patient visited clinics every 3 to 4 months, and plasma
glucose concertation, hypertension, and weight were calculated, the research continued for more
the eight years.
This study result shows that fewer control patients had higher hypertension readings than
those with high control. The low control patients showed a trend toward decreasing levels of
blood pressure, but it was a minimal decrease. The researchers suggest that their results show
that high control of hypertension did reduce their risk of death, strokes, and microvascular
disease (UK Prospective Diabetes Study Group, 1998).
A similar study aimed to examine the potential risk factors that influence high blood
pressure in Saudi Arabia (El Bcheraoui et al., 2014). The study included a total of 10,735
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participants from all regions in Saudi Arabia. It was indicated that age, gender, history of
diabetes, and hypercholesterolemia were significantly related to hypertension. Also, the study
revealed that the prevalence of hypertension was found to be lower among females comparing to
males. Contrary to previous research, smoking status, level of education, and level of physical
activity were not found to have significant effects on hypertension. Surprisingly, according to the
same study, hypertension is estimated to be the number one risk factor for death in Saudi Arabia,
as cited in the Global Burden of Disease 2010, GBD2010 report.
In the same context, Saeed also conducted a study to identify the potential risk factors
that influence high blood pressure in Saudi Arabia (A. A. W. Saeed, 2017). Demographics and
lifestyle characteristics such as gender, age, education, occupation, region, family income,
physical activity, fruit and vegetable consumption, and smoking status were included in the
study. Also, anthropometric and blood measurements such as Glucose, Cholesterol,
Triglycerides, and high-density lipoprotein were also included in the study. The results indicated
that there was a significant association between gender, age, education level, occupation,
physical activity, and high blood pressure. Moreover, it has been found that, among the
anthropometric and blood measurement, only high-density lipoprotein did not have a significant
impact on high blood pressure.
Saudi Arabia is not the only nation faced with problems of hypertension (Ong, Cheung,
Man, Lau, & Lam, 2007). Ong and colleagues found the prevalence and hypertension in the
period from 1999 to 2004. They found that there was no significant increase in hypertension
during that period, but also that overall three periods, hypertension increased as people aged and
with their body mass index BMI (Ong et al., 2007). In all 3 of the periods, the prevalence of
hypertension increased with increasing age and BMI. There were no significant differences
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between the sexes, but there was a difference based on education (Ong et al., 2007). One of the
factors also appears to be awareness. Those who are aware of their blood pressure and the
dangers of hypertension were more able to control it and get the treatment they need.
To assess the quality of healthcare services provided to individuals with high blood
pressure, Al-Saleem and his developed a questionnaire in the city of Aseer, Saudi Arabia (AlSaleem, Al-Shahrani, & Al-Khaldi, 2014). The study aimed to measure the satisfaction of
healthcare providers regarding factors such as patients’ cooperation and compliance with the
appointment system, availability of essential drugs for high blood pressure, and other relevant
factors. The results revealed that the satisfaction level of healthcare providers with community
participation was low (43%). Furthermore, the low satisfaction level of the healthcare providers
regarding patients’ compliance with the appointment (32%), and coordination with hospitals
(20%) were reported.
Nevertheless, given the stated facts about the burden of chronic diseases such as diabetes
and hypertension and their potential risk factors in Saudi Arabia, the need for improving the
quality of healthcare services to manage and control the prevalence of such diseases cannot be
more emphasized. Indeed, some researchers and healthcare providers started imitative programs
and interventions such as using the mobile phone technology, known as mhealth, to improve the
quality of healthcare service provided to diabetic and hypertensive patients in Saudi Arabia. Such
mhealth interventions are discussed in the subsequent sections.
2.4 Mhealth Interventions Related Diabetes type 2 and Hypertension in Saudi Arabia
The use of a technology-based intervention such as the mobile phone or mhealth to
enhance the quality of healthcare service has been explored recently. There are many advantages
to incorporating mobile phone technology in healthcare, such as its high penetration, ease of use,
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and cost-effectiveness make it a potential feasible intervention to address most of the challenges
of any healthcare system (Mokaya, 2010). According to the Information and Communications
Technology (ICT) facts and figures report of 2016, there were almost seven billion people in the
world who had access to a mobile phone network (SANOU, 2016). In developing nations,
around 3.6 billion people are subscribed to a mobile phone network (SANOU, 2016).
Community interventions can be useful in decreasing the number of people harmed by
diabetes. Afifi, Omar and El Raggal (2013) found in their research that if a person is not
genetically vulnerable to diabetes and exercises and maintain good body weight, that person will
be less likely to be a victim of diabetes. The food of the diet was more fiber and more
polyunsaturated to saturated fat ratio and decreased the average of the glycemic. Also, the other
factors that were important were not smoking, drinking alcohol in moderation, and normal
weight (Afifi, Omar, & El Raggal, 2015). Not only is it possible that people will be able to
control their diabetes, but it is also possible to aid in preventing them from getting diabetes.
Also, other studies reviewed the feasibility and effectiveness of using mobile health
applications in promoting better health conditions for patients with hypertension. In one study, a
review of current mhealth interventions and the evaluations of their effectiveness for the
management of hypertension and hyperlipidemia was presented (Rehman et al., 2017). The study
reported that using mhealth interventions such as SMS for management of hypertension was
effectively based on the literature. However, the cost-effectiveness of such interventions has not
been evaluated. Thus, the authors suggested that future research should consider the feasibility of
using mhealth interventions for the management of hypertension through its costs and benefits.
In South Africa, a mobile health intervention using SMS text messaging to promote
health knowledge for patients with hypertension was examined (Hacking et al., 2016b). The
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study included a total of 223 hypertensive patients who were tested for their current knowledge
of hypertension and were then randomly assigned to two groups: the intervention group and the
control group. Over a period of 17 weeks, patients in the intervention group received a total of 90
SMS text messages, including knowledge of hypertension and guidelines for lifestyle changes.
Consequently, patients in both groups were tested for their knowledge of hypertension using the
same questionnaire that was used before the intervention. The results showed that no significant
difference between the intervention and the control group regarding their knowledge of
hypertension was observed. However, the intervention group showed a positive increase in selfreported behavior change (Hacking et al., 2016a).
To explore the trends, opportunities, and challenges of mhealth, a literature survey was
conducted to achieve this goal (Jusoh, 2017). The author also surveyed the current mhealth
applications on Google Play. In reviewing the Apple App Store and the Google Play Store, more
than 60,000 mhealth applications (James, 2015). The majority of these applications, according to
the same study, were designed to provide health services in the areas of health fitness and selfhealth monitoring. Nonetheless, the study discussed some of the challenges of adopting the
mhealth technology, which includes lack of security considerations in some mhealth
applications, lack of usability, and lack of studies evaluating the effectiveness of mhealth
applications. Despite the reported issues of mhealth application, many opportunities are available
for researchers and healthcare providers to implement mhealth technology in order to improve
the quality of health service delivery.
In Saudi Arabia, many researchers and healthcare providers investigated the adoption of
mhealth interventions to improve healthcare services. One study used a mobile phone application
to improve healthcare service delivery at the Emergency Department (ED) in Saudi Arabia
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(Househ & Yunus, 2014). The developed mobile health application, which is called EDWaT,
aimed to reduce patients’ waiting time by providing real-time data about the flow of patients to
the emergency medical services (EMS) staff. The study also reported some of the challenges of
implementing the EDWaT, such as the lack of cooperation of some hospitals regarding sharing
the waiting times of their patients. Nevertheless, the effectiveness of EDWaT has not been
reported in the study.
In another study, a review of mobile technologies used to help individuals with special
needs was explored (Kanjo, Albarrak, Alhakbani, Altammami, & Alghamdi, 2013). The authors
organized a workshop hosting a total of 30 participants at King Saud University in Saudi Arabia.
The authors classified those with special needs into five categories, namely Memory Loss,
Visually Impaired, Hearing Problems, Learning Disability, Behavioral Problems, and Chronic
Diseases. Among the mobile applications that the study reported is Ariadne GPS, Talking Maps
for Visually Impaired individuals, and Noise Spy for individuals with Hearing Problems. The
study reported that awareness and cost are the main factors that limit individuals with special
needs from using mobile phone technology. The study also presented some recommendations to
integrate different mobile applications to improve the quality of healthcare services provided to
individuals with special needs.
In the same context, Uluc conducted a field survey study to identify the main challenges
of e-health in four countries, namely Turkey, the Kingdom of Saudi Arabia, Egypt and the
United Arab Emirates (Uluc & Ferman, 2016b). A total of 251 participants, including physicians,
healthcare IT professionals, and relevant government representatives, were chosen to complete
two questionnaires in the four selected countries. Based on participants’ feedback, a conceptual
framework for the development of e-health practices in the four selected countries was
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developed. The framework outlined the factors that may limit the successful implementation of
e-health in the selected countries, which include ICT Infrastructure and Readiness, Cultural
Adaptation, Regulations, Financing, Supply Chain Management, and Trust. The Analysis of
Variance (ANOVA) technique was used to determine the potential effect of these factors on the
development of e-health. The results indicated that all of the above factors have a significant
effect on the development of e-health in the selected countries.
Moreover, Saad conducted qualitative research to identify mhealth interventions adopted
by the Saudi Ministry of Health (SMOH) with the aim to improve healthcare service delivery in
Saudi Arabia (Saad, 2016). The author conducted a questionnaire to determine the most vital
mhealth administrations from the viewpoint of patients. The Technology Acceptance Model
(TAM) was used in this study to explore six areas of mhealth applications namely “appointment
reservation, open and update medical record, patient referee and consultation, physician
directory, request medical reports and health risk assessments” (Saad, 2016, p. 7). Nonetheless,
data analysis and findings of the study were not reported.
2.5

Mhealth and Prevention of Diabetes type 2 and Hypertension in Saudi Arabia

The applications of mhealth technology have also been used to prevent diseases such as
diabetes and hypertension. For example, Tate and his colleagues explored the success factors and
challenges of using mhealth technology to prevent obesity in children (Tate et al., 2013). The
study indicated that the adoption of mhealth intervention yielded several advantages, including
its cost-effectiveness, real-time data collection, and its flexibility regarding its application and
monitoring capabilities. On the other hand, the challenges of applying mhealth technology to
prevent chronic disease were also reported in the study. One of these challenges is the increase in
sedentary behavior. The second challenge is the declined ability to focus attention. In fact, these
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challenges, according to this study, negatively impact obesity in children due to the possible
prolonged communication with mhealth technology. Furthermore, the study also reported other
issues of the current mhealth applications such as data security, patient privacy, and lack of
evidence of the effectiveness of such applications.
Besides the documentation of the enablers and limitations of the adoption of mhealth
interventions in disease prevention, some studies reported successful implementation of mhealth
technology to prevent chronic diseases such as diabetes and high blood pressure. Hingle and his
colleagues developed a mhealth intervention aimed to prevent type 2 diabetes among children
aged 9 to 12 years old in Tucson, Arizona (Hingle et al., 2015). The developed intervention EPIC Kids ((Encourage – Practice - Inspire - Change) – was tested using a group-randomized
trial at three points in time (baseline, post-intervention, and follow up). A total of 60 kids at risk
of type 2 diabetes were recruited in the study. Anthropometric, behavioral, and physiological
factors were used to evaluate the effectiveness of this intervention. The study reported a potential
reduction in children’s high carbohydrate food intake, sugar-sweetened beverages, and a
sedentary lifestyle. Also, the study reported a possible increase in kids’ intake of vegetable and
whole-grain servings and physical activity.
In Sydney, Australia, Partridge and his colleagues conducted a randomized control trial to
examine the effectiveness of a mhealth intervention to prevent weight gain among young adults
(Partridge et al., 2015). The proposed mhealth intervention - TXT2BFiT – aimed to help young
adults improve their diet and promote exercise. A total of 250 participants aged from 18 to 35
years with a high risk of weight gain were recruited in the study. Bodyweight and height of the
participants were measured before and after the intervention. Also, participants in the control
group received eight text messages, one email, and five coaching calls as well as other
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supporting materials on a weekly basis. The results revealed that more than 90% of the
participants showed adherence to coaching calls and text messages. The results also showed
significant reductions in the consumption of sugary soft drinks, and energy-dense meals among
participants of the intervention group. Moreover, a significant increase in the consumption of
vegetables among participants of the intervention group has been reported.
Mhealth technology has also been used to provide care for patients with hypertension. In
one study, Diez-Canseco and his colleagues introduced an SMS intervention to prevent blood
pressure in different Latin American countries. A sample of 36 patients with hypertension was
chosen in each country to participate in the study. The patients received an initial set of 64 SMS
messages aimed to encourage healthier lifestyle changes. The messages included information
about salt and sodium intake, fruits and vegetables, fat and sugar consumption, and physical
activity. Patients’ feedback regarding the mhealth intervention was then assessed using a
questionnaire. The results revealed that more than 96% of the participants responded to the
questionnaire and provided an adequate understanding of the content of the SMS text messaging
intervention. The study concluded that the use of SMS text messaging could contribute to the
prevention of hypertension (Diez-Canseco et al., 2015).
In addition, a case study reviewed the feasibility of using a mobile phone application Dietary Approaches to Stop Hypertension (DASH) – for patients with hypertension (Mann,
Quintiliani, Reddy, Kitos, & Weng, 2014). In specific, the aim of developing DASH was to
promote prevention through behavioral change and lifestyle modifications for patients with
hypertension. The study reviewed the stages of developing DASH, starting from the design stage
and ending with the prototype stage. The study reported some of the potential challenges of using
the DASH in providing care for patients with hypertension, although no actual use of DASH was
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carried out in the study. Moreover, the study concluded that mobile health applications could
promote a behavioral change in patients with hypertension, given the availability of robust
infrastructure.
In developing countries, Déglise and his colleagues reviewed the applications of SMS
text messaging for disease prevention in the nation (Déglise, Suggs, & Odermatt, 2012). Among
the mhealth interventions reported is a mobile phone game called Freedom HIV/AIDS, which
was developed to promote awareness and provide information about HIV and AIDS in India. A
similar intervention called Star Project was initiated by the same company in six African
countries for the same purpose. The authors stated that most of the studies were pilot projects,
few including an evaluation. Limitations of the reported mhealth interventions included
language, the timing of messages, mobile network fluctuations, lack of financial incentives, data
privacy, and mobile phone turnover. (Déglise et al., 2012).
Limited research has been conducted on the use of mhealth technology to prevent
diseases in Saudi Arabia. Alqahtani conducted a pilot study to examine the feasibility of using a
mobile phone application to monitor the health conditions of travelers during the Hajj pilgrimage
of 2014 (A. S. Alqahtani et al., 2016). A cohort study was conducted in three phases: before,
during, and after Hajj 2014, including a questionnaire in each phase. The authors developed an
iPhone application – Hajj Health Diary – to monitor the health conditions of the travelers.
Participants in the study were recruited over two phases. The first phase of recruitment was
conducted using a travel seminar in Sydney, Australia, and the second phase of recruitment was
conducted virtually by releasing the Hajj Health Diary to the Apple app store. There were 41
respondents to the application aged between 21 and 61. The study revealed that more than half of
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the participants found the app to be convenient. The authors concluded that mobile phones could
feasibly be used to collect data, conducted surveys for disease prevention and control.
In another study, AlKlayb evaluated the effectiveness of a mobile phone application in
providing preventive dental care by educating mothers of children most aged at six years
(AlKlayb, Assery, AlQahtani, AlAnazi, & Pani, 2017). The authors developed a mobile phone
application - iTeethey™ - for IOS and Android operating systems, and it is available for free in
Google Play and Apple App Store. The application was distributed to 3879 mothers, 1055 of
whom downloaded the application at eight healthcare facilities in the cities of Riyadh and Najran
in Saudi Arabia. The authors reported that the use of the iTeethey™ significantly improved
mothers’ knowledge of oral health conditions after three months of using the application.
Moreover, there is a significantly higher level of maternal knowledge of mothers in Riyadh
comparing to those in Najran. The authors also found a positive correlation between the number
of children in the family and the change in the knowledge score.
2.6 Mhealth and Medication Adherence for Diabetes type 2 and Hypertension in Saudi Arabia
Several studies examined the use of mobile phone technology to manage chronic diseases
such as diabetes and hypertension. In one study, mobile phone technology was used to provide
management and education for patients with type 2 diabetes in Saudi Arabia (Alotaibi,
Istepanian, Sungoor, & Philip, 2014b). A mobile phone application – SAED – was developed to
help patients manage their diabetes. The SAED is composed of two components, namely the
“SAED mobile patient/healthcare provider” and “the SAED intelligent diabetes management”
(Alotaibi et al., 2014b, p. 1). The first component consisted of two units: a diabetic patient unit
designed to collect patients’ information such as blood glucose levels; and a specialist diabetic
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nurse unit designed to facilitated communication between nurses and diabetic patients. The
second component consisted of four modules, namely a SAED database module for storing
patients’ information, an intelligent decision support module for data processes and analysis,
SAED SMS reminder module, and diabetes educational module. Patients information such as
glucose levels is transferred to SAED from the glucose meter, see figure 5.

Figure 5 Data transfer from glucose meter to SAED application(Alotaibi, Istepanian, Sungoor, &
Philip, 2014a)
Also, a randomized control trial was conducted over a six-month period to evaluate the
effectiveness of SAED to manage and educate diabetic patients in Tabuk, Saudi Arabia (Alotaibi
et al., 2016). A total of 20 patients aged from 20 to 65 years were randomly nominated to
contribute to the study, and they were separated into two groups, with ten patients allocated to
the nonintervention group and ten patients allocated to the intervention group. Patients’
information, such as blood glucose levels, were recorded two to three times a day on two to three
different days a week. Moreover, patients in the control group received weekly SMS text
messages to promote their knowledge of diabetes and related risk factors. The results revealed a
significant reduction in blood sugar levels of patients in the intervention group compared to the
control group. Furthermore, patients’ knowledge about diabetes was higher in the intervention
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group comparing to the control group, although both groups showed a significant improvement
in their knowledge before and after the intervention.
Furthermore, a nonrandomized experiment was used to evaluate the effectiveness of
mobile phone SMS text messaging to control blood sugar levels of patients with type 2 diabetes
in Riyadh, Saudi Arabia (B. B. Abbas et al., 2015). The study lasted for four months and
included a sample of 100 patients with type 2 diabetes. Patients’ relevant data were recorded
before and after the SMS intervention. The developed SMS intervention was designed to
increase patients’ knowledge of diabetes by sending five to seven messages per week, providing
general information about diabetes, such as its symptoms, signs, diagnosis, etc. The results
revealed that a significant reduction in fasting blood sugar was observed after the intervention.
Also, patients’ knowledge of diabetes was significantly improved following the intervention.
For the management of hypertension, Kang and Park (2016) developed a mobile phone
application that was based on clinical practice guidelines (CPGs) in Seoul, South Korea. The
hypertension management application (HMA) included medical items such as blood pressure
readings, medication records, and lifestyle data. A sample of 38 patients with hypertension was
selected to participate in the study. The mobile phone application was evaluated regarding
“perceived usefulness, user satisfaction, and medication adherence” (Kang & Park, 2016, p. 1).
The results showed that patients’ medication adherence was significantly improved since their
use of HMA. Also, the scores of the perceived usefulness and user satisfaction were above 3 out
of 5 (Kang & Park, 2016).
To evaluate the feasibility of extracting data from Electronic Medical Records (EMR),
Velthoven conducted a comparative study in 16 countries, including Saudi Arabia (van
Velthoven, Mastellos, Majeed, O’Donoghue, & Car, 2016). Moreover, the study aimed to
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measure the quality, consistency, and extent of adopting EMR data for managing type 2 diabetes
in the selected countries. Structured questionnaire targeted physicians, scholars, and relevant
stakeholders to collect information regarding the adoption of EMR in these countries. The
questionnaire included questions on the treatment of type 2 diabetes and the adoption of EMR in
this regard. The results indicated that Saudi Arabia was among the countries that had high EMR
adoption rates.
2.7

Mhealth and Diagnostic of Diseases

Many researchers have investigated the effectiveness of using mhealth technology in the
diagnosis of some diseases. In the United Kingdom, for instance, Eze and his colleagues used
mobile phone digital photos to examine the accuracy of diagnosing some ear, nose, and throat
(ENT) emergency in radiological investigations (Eze, Lo, Bray, & Toma, 2005). Fourteen
patients were randomly selected to participate in the study. A comparison between CT scans and
X-ray images transmitted via a mobile phone and images processed via a conventional X-ray box
was carried out by six ENT consultants and five registered specialists. The results showed that no
incorrect diagnosis was reported for cases included in the study. Moreover, the study concluded
that there are significant differences in terms of accuracy, confidence in diagnosis, and
compatibility.
In rural New Zealand, a study was to evaluate the feasibility of using mobile phone
images in the after-hours triage of primary care (Jayaraman, Kennedy, Dutu, & Lawrenson,
2008). A total of 480 patients attending two healthcare facilities in rural New Zealand were
surveyed. Moreover, 30 health professionals divided into three groups were recruited and given a
quiz regarding the use of mobile phone images and their effect on the diagnosis of confidence.
The study revealed that the use of mobile phone cameras at diagnosis was acceptable by patients
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and medical specialists, especially those who work in rural areas. The study also reported that the
mobile phone images in a clinical environment significantly increased diagnostic confidence in
most of the cases considered.
Also, Breslauer and his colleagues evaluated the feasibility of incorporating a microscope
to a mobile phone for diagnosis of some diseases such as Malaria, Anemia, tuberculosis in
California, USA (Breslauer et al., 2009). A Nokia N73 mobile phone equipped with a 3.2megapixel camera was used in this study to capture images of malaria-infected blood samples
and sickle cell anemia blood samples. The results showed that the resolutions of the blood cell
samples were higher than the expected level. Moreover, the authors indicated that the use of this
mobile-based integrated system yielded many advantages, such as the cost-effectiveness and ease
of use of technology.
In the developing countries, Breslauer and colleagues examined the effectiveness of using
mobile phone text messaging in the diagnosis of HIV infection among infants in Zambia
(Breslauer et al., 2009). To reduce the turnaround time of blood test results, the authors
introduced an SMS text messaging intervention to report the results to certain healthcare
facilities for results analysis. The turnaround time of the results sent by mail to 10 healthcare
facilities was recorded and used as baseline data. The results revealed that a significant reduction
in the mean turnaround time was observed in nine out of 10 healthcare facilities using the SMS
text messaging intervention.
Chin and his colleagues designed a mhealth intervention that consisted of a mobile phone
and a satellite communication technology for diagnosing HIV in Kigali, Rwanda (Chin et al.,
2013). The developed mhealth intervention – mChip – was used to collect blood samples from
patients with HIV as well as to track and analyze these data for diagnosis purposes. A total of
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167 participants were recruited in the study. The study indicated that the sensitivity and
specificity of the diagnosis were 100% in most of the cases. The study also indicated that the use
of mChip was effective in the diagnosis of HIV in this set.
Another study examined the influence of the diagnosis of obese and overweight persons
by mobile decision support systems for individuals in the United States (Lee et al., 2009). A
randomized controlled trial with two groups was designed to explore the results. The results
presented that there was a significant difference between the three groups yielding more obesityrelated diagnoses.
Few researchers have evaluated the role of mhealth interventions to diagnose diseases in
developing countries. Quinley et al. (2011) examined the use of a mobile phone camera to
diagnose women with HIV in Gaborone, Botswana, for the potential risk of cervical cancer. The
authors used a 5-megapixel-camera mobile phone manufactured by Samsung to take the images
of the cervix and then transmitted by Multimedia Messaging Service (MMS) to a remote location
where an expert performed the diagnosis process, after which a visual inspection was carried out
by midwife nurses. The results revealed that nearly 67% of the images were of good quality for
the expert to perform the diagnosis. Also, identical results of the visual inspection and the expert
were obtained in more than 80% of the cases (Quinley et al., 2011).
Another study evaluated the effectiveness of using the mobile phone to diagnose patients
with common skin diseases in Cairo, Egypt (Tran et al., 2011). Following a face-to-face
inspection, the relevant medical information and dermatologic images of 30 patients were sent to
an online database and then evaluated by two senior dermatologists independently using a 5megapixel-camera mobile phone model U900 manufactured by Samsung. The results showed
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that consistency in diagnoses between the face-to-face and remote diagnosis was achieved, on
average, in 75% of the cases (Tran et al., 2011).
To the knowledge of the author, no research studies using mhealth technology for disease
diagnosis have been reported in Saudi Arabia. This represents a gap in the literature. Thus, future
research should focus on exploring the effectiveness of using mhealth interventions in the
diagnosis of chronic diseases.
2.8

Potential mhealth Interventions for Replication in the Developing Countries

Given the formerly discussed mhealth interventions in Saudi Arabia and their limited
effects in providing high-quality healthcare services, there are many other successful
implementations of mhealth interventions in the developed nations that could be replicated in
Saudi Arabia. For instance, one study evaluated the effectiveness of a mobile phone application
that was designed to help elderly patients with diabetes, high cholesterol, and hypertension
manage their health conditions in an outpatient clinic in Health Centre South in Vienna, Austria
(Brath et al., 2013). Specifically, the mhealth application was developed based on a remote
medication adherence measurement system (mAMS) to assess the patient’s behavior and
adherence to four medications. Using a randomized single-blinded (doctor blinded), controlled,
single-center study with a crossover design, 150 participants with the potential risk of
cardiovascular conditions accompanying by at least two of type 2 diabetes, hypertension, and
hypercholesterolemia were divided into two groups. The study revealed that a significant
difference in adherence to one medication between the two groups was observed, while no
significant differences in adherence to the other three medications were reported (Brath et al.,
2013).
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Another study evaluated the feasibility of using a mhealth intervention to help patients
manage their diabetes in Boston, USA (Hanauer, Wentzell, Laffel, & Laffel, 2009). The
developed mhealth intervention consisted of SMS text messaging and email reminders that
aimed to help patients monitor their blood glucose levels. A total of 40 individuals with diabetes
were randomly selected to participate in the study. The selected participants received SMS text
messages or email, reminding them to check and resend their blood glucose levels during a three
months period. The results of the blood glucose levels were then analyzed using a Computerized
Automated Reminder Diabetes System (CARDS). The study indicated that the response rate of
the participants who received the SMS text messages was significantly higher than that of those
who received the email reminder. Thus, it can be concluded that using mobile phone SMS text
messages to collect patients’ information provided more acceptability comparing to other
technologies such as using email.
In Nashville, Tennessee, USA, Nelson, and his colleagues conducted a study to examine
the relationship between patients’ certain characteristics and the level of participation in a mobile
Health medication adherence intervention (MED) for patients with type 2 diabetes (Nelson et al.,
2015). The MED intervention consisted of SMS text messaging and phone calls that aimed to
promote medication adherence and medication reminders (Nelson et al., 2015, p. 13). Eighty
patients were selected to participate in the study. Data collected from patients included
demographic characteristics, health literacy, and depressive symptoms. The study reported that
significant associations were found between patients’ characteristics and the prospect of
participation in the mhealth intervention program.
In the developing countries, Abbas and his colleagues introduced mhealth applications to
improve healthcare service delivery in Karachi, Pakistan (Z. Abbas, Burney, & Bari, 2016). The
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first application – DocsLab – was designed to help individuals search for nearby specialists or
laboratories throughout the city of Karachi. Moreover, the application provides the location of
the clinic and the time of the day the specialists are available. The data incorporated into the
application included around 500 specialists in different areas in the city. The second application
– Drugs-Pharma – was designed to provide a variety of services that include, but not limited to:
searching for a certain medicine, its usage, its availability, its form, and its possible side effects;
providing different brand names of a certain drug as well as the chemical name in case the brand
name is not known; listing pricing information of different brands; providing alternative drugs in
case the prescribed drug cannot be found.
Moreover, Abbas and his colleagues reported a third mhealth application to improve
healthcare service in Pakistan. This application – Healthcare App – was designed to provide
general information about illnesses and medical terms. This application was developed for the
Android operating system only due to its wide use in the city. Regardless of the implementations
of these applications, no evaluation of their effectiveness has been reported (Z. Abbas et al.,
2016).
Also, Wolff-Piggott and his colleagues presented an implementation of the mhealth
application in a public clinic in South Africa (Wolff-Piggott, Coleman, & Rivett, 2017). The
mhealth application – MomConnect – was designed to provide information to pregnant women
during different stages of pregnancy. The goal of the study was to evaluate clinic workers’
feedback regarding the use of the application. To collect relevant information regarding workers’
experience with the implementation of the mhealth program, interviews and observation sessions
were carried out. The authors identified the hierarchical relationships between professional
nurses and support staff as one the influenced the performance of the MomConnect.
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Hoque, 2017 conducted a study to identify the factors that may affect the use of ehealth
by patients in Bangladesh. These factors included perceived usefulness, perceived ease of use,
privacy, ant-trust. These factors have been evaluated from patients’ perspectives using the
technology acceptance model (TAM). To collect data, a survey was designed, and 350
participants from both private and public hospitals in Dhaka were included in the study. The
results demonstrated that perceived ease of use, perceived usefulness, and trust significantly
affected patients’ intent to use ehealth (Hoque, Bao, & Sorwar, 2017).
2.9

Mobile Health Application in Saudi Arabia

Mobile devices are overtaking PCs in today’s world as “there are currently about 7.6
billion mobile connections covering 4.7 billion subscribers” (M. M. Alqahtani & Atkins, 2017, p.
222). In fact, mobile internet usage around the globe has become greater than the use of personal
computers. Saudi Arabia is just one of many countries in which mobile devices are used more
than PCs. It is also true that the value of these mobile devices has been appreciated and reported.
For example, the King’s Fahad report. This report listed technologies that are likely to create a
revolution in healthcare. Smartphones are one of these devices, and according to the King’s
Fahad report, their usage in the healthcare field will result in cost reduction for the healthcare
industry, better outcomes for patients, and proactive and targeted care improvements. Some
Smartphone apps can monitor patients in real-time and can aid in analytics. It is expected that
mobile health applications will generate revenue worth $23 billion when measured globally (M.
M. Alqahtani & Atkins, 2017).
A case study in Saudi Arabia found that there is an excellent Electronic Health Records
give information on demand (M. M. Alqahtani & Atkins, 2017). When patients believe that
quick access to records will improve their care, they will be likely to use the EHR app. Their
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ideas about the use of apps aid in getting doctors and other clinical staff to use them. If a doctor
is unsure of a diagnosis, for example, he or she cannot give the patient the proper treatment. If
the diagnosis can be reached the patients by Smartphones or other apps, health care improves in
quality and quantity. More patients mean that more people who are ill will get the treatment they
need in time.
In Saudi Arabia, there has been an adaptation of EHR (Electronic Health Records) at a
growing rate. The EHR use rate has also been growing over time (Alsulame, Khalifa, & Househ,
2016). However, the rate of grown is higher in some parts of the country than in others. Also, the
EHR has been adopted by a few organizations, and they have been proving that EHR is
successful. Both EHR and Electronic Medical Records (EMR) have faced some barriers to
implementation. While this did not shut down apps such as EHR, it did make the implementation
process very time-consuming. For example, The Ministry of National Guard Health Affairs
(MNGHA) started by creating a vision consisting of implementing EHR in three different areas
in Saudi Arabia (Alsulame et al., 2016). Next, it established project committees and a project
team to undertake the implementation of the system. These undertakings together required ten
years to implement.
In the Eastern area of Saudi Arabia, doctors have used the EHR effectively. However,
EHR is some barrier to the highest rates of use. Research on this subject by El Mahalli (2015)
investigated some possible excuses for missed appointments that included financial, technical,
time, psychological, social, legal, and organizational and change process difficulties. Saudi
Arabia does emphasize using electronic devices for many purposes, including keeping health
records and sending those records to those who need them. To discover the reasons for missed
appointments, the study used three separate hospitals (governmental), and all are general
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hospitals. The departments in the study were many included diabetes mellitus. All of these
hospital departments had adopted or were adopting EHR at the time that this study was done.
The study was done in a questionnaire form (El Mahalli, 2015). Information gathered included
the demographics of physicians, functions of the EHR system, and barriers to use of EHR
systems in table 9.
Table 9 Barriers of physicians with the electronic health records system(El Mahalli, 2015)

This chart shows that they faced barriers that involved an inability for a short time to
access medical records. They also were concerned about the degree of fastness. There was in
attaining information and communication with each other and patients. They did not appear to
have a particularly high concern for confidentiality, etc. However, in each area, there were
concerns, and usually, they were expressed by over half of the physicians utilizing the system.
This suggests that Saudi Arabia is effectively using EHR to some degree, but not to a high
enough degree.
The results of the study found that most of the functions being studied were under-used
(El Mahalli, 2015). The reasons presented showed that most of the barriers were related to the
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system hanging up and loss of access to medical records for short times. There was a lack of
speed in utilizing the system as well. A major complaint was that there was a low adoption of the
chart system. There was also the low adoption of e-prescribing, which is important to improve
the efficiency of patient care (El Mahalli, 2015). Progress needs to be made in medication errors
and adverse drug reactions by patients. Few complaints were made involving a lack of faith in
the system. However, there was little communication used by hospitals. The EHR system has
many tools for communication that allowed information to be exchanged between physicians and
between physicians and patients. Email is used more often than other tools, and fax is used for
transforming documents either inside or outside. SMS is additionally used to keep patients
mindful of their arrangements when they are expected. However, none of these means of
communication were used in any of these hospitals. One reason may be that in some cases, there
might be a lack of access to the internet within the hospital. Some doctors claimed that there was
also difficult to obtain records if a computer either crashes or in case of a power failure. These
are barriers to good communication.
Several other problems arose in this study, and one is that there may not be enough
computer knowledge among some of the staff of these hospitals. Another complaint was that
EHR was too complicated, which suggests that hospitals may not be instituting training for those
who lack some of the needed skills. The author suggests that this training may be timeconsuming for busy doctors and other personnel, but it is a necessity. If EHR does not work only
because no one knows how to use it, then all of its benefits are lost.
Saudi Arabia has a unique need for mobile apps during the Hajj period. Muslims who are
able to do so are required by their religion to make at least one pilgrimage during their lifetimes
to Saudi Arabia, and these people come from all over the world. With so many people being
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involved in the same travel and rituals at the same time, many entities have created apps to aid
pilgrims in their travel. There are apps for travel to the area and visit more than one holy place.
They may need apps that aid them in finding the locations of each visit if they undertake more
than one, and for many other purposes, including health services (E. A. Khan & Shambour,
2017) such as cardiology and the symptoms of heart failure.
2.9.1

Diabetes and Hypertension Management with Mobile Health Technology

Mobile Health technology is used to help doctors and patients manage diabetes. While no
known medication can cure diabetes, it can be managed effectively. Electronic technology works
well to aid in the management of diabetic patients. These devices have been tested for efficacy,
and some research supports that they are effective. Kirwan, Vandelenotte, Fenning, & Duncan
(2013) investigated the use of smartphones when used by Type 1 diabetics. The researchers
recruited patients with type 1 diabetes in Australia. The research went for six months, and there
was a third-month follow-up as well. The researchers divided the 72 subjects into two groups
with one group acting as a control group and the second group as the intervention group. They
found that the control group was less successful than the intervention group at bringing down
their glucose level. They support the use of these apps (Kirwan, Vandelanotte, Fenning, &
Duncan, 2013).
One mobile health device is the Few Touch Application or FTA that supports a patient’s
efforts to manage their diabetes (Årsand et al., 2012, p. 1197). It is a mobile phone-based diary
that can update the information both by hand and automatically by wireless transfer and allows
the possibility of keeping track of personal health goals. The application can be used by patients
with type 1 and type 2 diabetes for the transfer of blood glucose data, receiving educational SMS
text messaging, receiving dietary information on diabetes, and tracking physical activities. The
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authors found that developed applications were easy to use in terms of data transfer. The
applications also facilitated the communications between patients, their patents, and healthcare
professionals. The findings also showed that mHealth apps such as the FTA are precious in
allowing patients to feel empowered to be more active in their health efforts.
Weinstein et al. (2014) recognized the reality that about the time that this article was
written, the Affordable Care Act was about to be implemented. That Act provides rewards from
the government's inefficiency in the delivery of healthcare. The authors outline the success
factors in telemedicine. These are the specific factors that need to be present for the success of
telemedicine. In fact, that possibility of success comes from the fact that what the healthcare
providers will have to provide (and correct) are the ones that lead to more efficiency. When
telemedicine is used, less time is wasted in completing various tasks such as communication and
training for various needs (Weinstein et al., 2014). Some barriers do exist, however. Long-term
success is part of efficacy. If healthcare institutions and people find that they do not work, they
have spent time and money on something they must throw away.
Goya and Cafazzo (2013) believe there is a gap in that not everyone has access to the
devices used in mhealth. The researchers claim that there are problems in the use of these
devices that make them less valuable than they should be. They claim that there is a high
likelihood that they will not enter data perfectly, and even if they do, there is an inability to get
enough data to the healthcare provider to make good decisions for the patient. Also, there is often
no real-time feedback and lack of actual behavior change by the patient to make these mobile
phone apps to be useful (Goyal & Cafazzo, 2013). In fact, if those problems are not overcome,
the apps may not be used or respected at all. These devices should be used more efficiently and
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realistically. There needs to be better communication in real-time, the ability to capture data, and
the ability to provide support for decisions.
These researchers point out that finding out that one has diabetes can cause psychological
stress in patients. Also, they must go through the process of understanding it, finding foods to eat
that will make it unlikely that they will have unusual problems, and how to deal with devices that
can help them and make their life simpler, but starts out by making it more difficult. The
researchers criticize many apps, in fact, because “only 20% of the apps had an educational
component, of which only 1/5 delivered personal feedback” (Goyal & Cafazzo, 2013, p. 1068).
The problem is not with the diabetic, but with the devices and their manufacturers. The apps are
fine and can work well, but too many apps do not provide support for those who must learn to
use them.
Sieverdes & Jenkins (2013), claim that mobile health technology is a valuable method of
managing diabetes. They point out that there are many people with diabetes, but less than half of
them have good control over their diseases. They regard mobile health technology as being an
“innovative approach” (Sieverdes, Treiber, Jenkins, & Hermayer, 2013, p. 289) to diabetes
management. The technology is most helpful when it can support the guidelines given to people
with diabetes-related to controlling and monitoring their blood glucose. They suggest that mobile
apps are good and describe each of the values of the various apps for people with diabetes. They
clearly support mhealth but at a shallower nature (Sieverdes et al., 2013).
Mobile health applications are being used in managing diabetes, but different apps may
be useful for different people and purposes (Eng & Lee, 2013). The authors reviewed the mobile
health application that focused on endocrine disease and found that there was a “higher
percentage of relevant apps in our searches of the iPhone app store compared with the Android
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marketplace” (Eng & Lee, 2013, p. 1). At the iPhone store, most apps focused on health tracking
on such indicators as blood sugars, insulin doses, and carbohydrates. These required that the
person manually enter the medical data. Only two of the mobile health applications directly put
blood in sugars based on glucometers that were added or a part of the cell phone. The rest of the
applications consisted of training uses, food databases, and social blogs, as well as those directed
by physicians. Some application calculated the insulin dose and met the criteria technically to be
a regulated mobile app but failed to find any indication that there had been Food and Drug
Administration (FDA) approval. Nevertheless, the consumers were able to purchase and use
them. Table 10 shows the available applications and their features:

Table 10 apps and features (Eng & Lee, 2013)
Application name

Operation System

Description

Welldoc Diabetes
Manager

IOS/Android

Graphs, graphs, blood glucose maps. Provides
customized guidance and encouragement to
patients through a patented analysis framework,
delivered via an organization or contractor of
health care, safely transmitted to a cloud, and
embedded with an electronic record.

Glucose Buddy

IOS/Android

Glucose in plasma, glucose, the dosage of
insulin, habits. Blood sugar can be tested for the
alert. Including a menu and a platform for the
culture.

GoMeals

IOS/Android

Logs glucose in the body, calories, nutrients, and
movement, which provides an interactive diet
database.
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Diabetic Connect

IOS/Android

Links to a diabetic care network, which creates a
forum where people with diabetes can speak to
other people.

Glucagon

IOS

Shows users how to manage Glucagon correctly.
May prepare memoranda while evaluating the
operation.

Calorie Counter

IOS/Android

Enables consumers to check barcodes on food
for consumer details

Nike Fuel Band

IOS/Android

Needs an additional wearable tracker, which
tracks consumer movements and daily activities.

The above table does not include all possible apps, but it does provide information as to
its cost (these apps are quite inexpensive) or whether they have approval from the FDA. These
authors make it clear that the devices might not be as accurate as they should be, but without
oversight by the FDA, there is no way to be sure of their accuracy.
El-Gayar et al. (2013) Researched mobile applications for diabetes. They indicated that
while Arsand et al. (2012) reviewed some of the tools for diabetes management, but did not
provide any detailed on the functionality of these smartphones and how they managed to
compare them with the clinical guidelines. El-Gayar et al. (2013) wanted to fill in that gap “by
evaluating the functional requirement with other, related issues for large-scale adoption of these
interventions” (El-Gayar, Timsina, Nawar, & Eid, 2013, p. 247). Their purpose is to determine
whether these apps have helped people with diabetes to self-manage.
They researched various apps, but only selected those with “following characteristics:
•

Support for blood glucose monitoring as a minimum requirement
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•

The patient as the intended primary user of the application to be used as an enabler for
diabetes self-management by supporting one or more of the self-management tasks” (ElGayar et al., 2013, p. 248).

The apps used in this case showed that there are not only many different apps but also many that
deal with blood sure, which is important for a person with diabetes.
The authors concluded that mobile apps often are beneficial to patients who are already
keeping paper logbooks. The electronic system is better, faster, and open to allowing data to be
easily shared with clinicians or certified diabetes educators for the purpose of review. In general,
most made communications much easier. The articles used to determine the valuation of the app,
and some found that there was little or no benefit with the use of that app. However, only two
articles of 16 gave that report. The others had at least some value, especially regarding recording
medication, blood glucose measurement, etc. if they can be used relatively easily, they can help
those who are involved in trying to keep track of information easily and quickly.
The people with diabetics are of all ages, from children to the elderly. (2014) Researched
mobile applications that can be used by older people. The subjects of this research were diabetics
who were 50 years old or more. They did a systematic review of all the diabetic apps for IOS and
Android. The purpose was to find out if apps could be improved so that they could be used by
older people who might have poorer eyesight or other problems associated with age. They
looked at a “range of functions, target user groups languages, acquisition costs, user ratings,
available interfaces, and the connection between acquisition costs and user ratings” (Arnhold,
Quade, & Kirch, 2014, p. 1). They also discerned whether the apps could meet the needs of those
people with diabetes who were aged 50 or older. Also, the researchers present the requirements
for apps that consider the difficulties that senior citizens can have in reading and understanding
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what mobile applications can do for them. This researcher found that the usability of apps for
diabetic patients over the age of 50 was between moderate and good. The multifunctional apps
performed worse on the item of stability. The best feature was the screen reader (Arnhold et al.,
2014).
2.10

Patients’ Compliance with Medications and Appointments in Saudi Arabia

In addressing the issue of diabetes and hypertension in Saudi Arabia, the important
problem is that some patients miss their physician appointments. In fact, not all patients are
compliant in general. Compliance in healthcare can be defined as “the extent to which a patient’s
behavior…coincides with the healthcare provider’s recommendations for health” (A. R. Khan et
al., 2012, p. 26). If the patient missed appointments, that patient is as noncompliant as the patient
that never misses an appointment but does not follow what the physician informs the patient that
he or she must do in order to deal with the disease. In healthcare, patient non-compliance is a
serious problem that makes it difficult for physicians to give the best health care. Noncompliance
is reported all over the world, and in one study, researchers found that one third to one-half of all
American patients are non-complaint in some way (A. R. Khan et al., 2012). In developing
countries, the extent of noncompliance is likely worse. Noncompliance is dangerous, especially
for those with chronic diseases such as diabetes, are more likely to go through serious difficulties
in the long and short-term (A. R. Khan et al., 2012).
The problem of noncompliance is present in Saudi Arabia, as in any other country. In
Saudi Arabia, the eastern and central regions of the country have huge numbers of patients who
missed their appointments reached (23.7% and 30%, respectively) (Alhamad, 2013b). These
appointments have economic and clinical impacts. For patients, it could mean missing out on
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treatment or screening for the illness they may have. This problem of missing appointments
contributes to less control f for patients.
Research by Alhamad (2013) addressed this issue by exploring reasons that patients
missed appointments in general clinics in Riyadh Military Hospital. The patients involved in this
study were either patients who missed at least one appointment that had been scheduled ahead of
time, or they were patients who came so late to their appointments that they were not seen at all
even though they were technically present in the clinic. There were 654 subjects in the research.
Upon completion of this study, the author found that the most significant reasons for missing
appointments were difficulties for booking a new appointment, long-distance between the
patients and the clinic, work commitment, and difficulty in transportation. The following table
reveals all of the reasons mentioned by subjects (Alhamad, 2013a).
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Table 11 Causes of Missing Appointments Reported (Alhamad, 2013a)

The above table suggests that the reasons for missing appointments were mainly related to the
patients’ problems rather than difficulties with staff. Patients might forget the appointment or not
be able to attend for some reason, such as illness.
A second study on the issue of noncompliance for diabetic patients was carried out by
Khattab, Abollfotouh, Khan, Humaid &Al Kaidi (1999) in Saudi Arabia. This study checked for
noncompliance among people with diabetes with diet, drugs, and the appointment system.
Compliance for appointments was based on the number of visits during a six-month period.
“Great compliance was recorded when the patient went to the facility on in excess of two events,
reasonable compliance was recorded when the patient went to on just a single event, and poor
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compliance was recorded when the patient had not gone to the center over a six-month time
frame” (Khattab, 1999, p. 756). The following figure 6 shows the outcome of appointment
compliance:

Figure 6 Patterns of compliance by diabetic patients(Khattab, 1999)
By far, most patients were compliant with their appointments, and about half that number rated
poor in compliance.
Salam & Siddiqui (2013) also investigated noncompliance, focusing on diet, exercise,
medication, and follow-up. While the researchers did not directly investigate whether
appointments were missed, they did investigate follow-up, which is an important issue in
diabetes as it is a chronic disease. This study investigated some possible problems people with
diabetes may have had with compliance, such as following diet suggestions, exercise
requirements, taking medication, and follow-up. The participants were grouped by age group and

66

gender as well. The following table 12 shows the outcome of the investigation (Salam &
Siddiqui, 2013).
Table 12 Aspects of Compliance (Salam & Siddiqui, 2013)
Variables

Diet

Exercise

Medication

Follow-up

Compliant

Compliant

Compliant

Compliant

Number %

Number %

Number %

Number %

(43.4) 21 (100.0)

17 (81.0)

5 (23.8)

21* (100.0)

128 (44.8)

231 (80.8)

216 (75.5)

56 (56.6)

32 (32.3)

77 (77.8)

72 (72.7)

Male

140 (57.6)

96 (39.5)

190 (78.2)

197* (81.1)

Female

90 (55.2)

81* (49.7)

123 (75.5)

112 (68.7)

Illiterate

88 (51.5)

69 (40.4)

132 (77.2)

137 (80.1)

Primary/inter

64 (69.6)

54 (58.7)

73 (79.3)

68 (73.9)

Secondary

37 (44.6)

22 (26.5)

60 (72.3)

56 (67.5)

University

41 (68.3)

32 (53.3)

48 (80.0)

48 (80.0)

Age group <40

40-60 years (44.8) 153 (53.5)
> 60

Gender

Education

The findings, in this case, were that there is little compliance in most cases with diet and
exercise being the main two categories in which there were failures. Most of the participants did
well on follow up while in other areas, there was a lack of compliance. Follow up does not
necessarily mean that a patient will comply with what they learn dur8ing an appointment or
follow-up.
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One study on the issue of compliance in diabetes patients is a review of the literature on
the subject undertaken by Al Qasem et al. (2011). They found a total of 19 studies that were
relevant to the issue. They were looking at the degree and indicators of nonadherence to
medicine while tending to different health conditions. They evaluate that nonadherence occurred
between 1.4% to 88% (Al Qasem et al., 2011). They found that the reasons given for
nonadherence included such excuses us having forgotten about the medication, side effects I
some cases, wanting a holiday from taking the medication the sense that the medication was not
helping, feeling well, and a poor education about the importance of the medication (Al Qasem et
al., 2011). There was no breakdown indicating the degree of nonadherence for the various
chronic diseases.
Further, Al Harbi et al. (2015) investigated the degree to which patients in primary care
in Saudi Arabia who have diabetes are adhering the American Diabetes Association’s standards
of care. Investigations into the degree to which Saudi citizens with diabetes are cared for in
primary care settings and these researchers want to see if these patients are adhering to 11 ADA
standards of the care of diabetics. The study was record-based and included a one-year follow-up
of patients with diabetic patients. The study was undertaken at the Wazarat HealthCare facility
in Riyadh, Saudi Arabia. There were 450 type2 diabetes patients in this study with a mean age of
31.4 (Al Harbi et al., 2015).
When the research was completed, the results were not as good as they might have been.
The study included 450 patients: included men and women. The information about these people
is found in the following table 13:
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Table 13 Statistic qualities and diabetic medicines of 450 sort two diabetic patients going to an
essential care focus in Saudi Arabia (Al Harbi et al., 2015).

The table above shows that the majority of the patients were between 50 and 69, that less than
half were male, and about 85% were either overweight or obese.
The researchers pointed out that there was a large difference in adherence from 92.9% to 35.6%.
Researchers have also dealt with compliance and adherence in a family practice setting in
Saudi Arabia. The study’s purpose was to identify the reasons that some patients comply with the
diet, anti-diabetic drugs, and appointments. Their research showed that when it comes to diet,
there was good compliance for men, but not for women. Compliance regarding appointments
was related to good care. Compliance with medications did not show an association with any of
the determinants. The only determinants of control of diabetes were duration and care. These two
determinants were the only ones that had any effect (Khattab, 1999).
There are connections between some diseases for which people are not always compliant
with their doctor’s request. AlHewitt (2014) provides research on the degree to which people
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adhere to long-term therapies as related to their beliefs about the medications they are assigned.
The research was undertaken in family repeated medicine clinics. AlHewitt evaluated the
relationship between compliance with their medications, and their beliefs about medicine,
adequate information about those medications and other factors. This research was conducted
through questionnaires (AlHewiti, 2014)
The results of this investigation should show that more than half reported that they were
not very compliant with their medication requirements.
AlHewiti points out that education is very important in order to improve the degree of
compliance by people with diabetes. Patients are going to be more likely to comply with
medications if they understand them well (AlHewiti, 2014).
Compliance with medication can also occur due to health beliefs. Alatawi, Kavookjian,
Ekong, & Alraees (2016) investigated this possibility. Their purpose was to evaluate the selfreport of drug-taking in Saudi Arabia. Each purpose related to those with type 2 diabetes. They
did a cross-sectional study at an outpatient pharmacy. They gathered statics and analyzed them to
explain self-report adherence.
The researchers found that most patients reported taking their medications. However,
about 60% were not taking it in the number of times per day that was required. About 50% were
not taking doses at the correct time, and more than 40% reported reducing in adherence at the
phase of change. The patients that perceived that the medication was helping them and those who
believed in their ability to make decisions were the ones that more likely to adhere to medication
requirements (Alatawi et al., 2016).
An investigation of hospital pharmacy practice in Saudi Arabia was conducted by
Alsultan, Mayet, Khurshid, Salamah & Al-jedai (2012). A national survey was conducted to
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assess hospital pharmacists practice in Riyadh, Saudi Arabia. They want to discover if there were
effective monitoring and patient education. They asked 48 pharmacy managers in different
hospitals to participate in this study. They used specific pharmacist’s questionnaire. Of these
hospitals, about 60% only did monitoring for 26% of their patients. There were some
shortcomings in that the percentage of patients they monitored tended to be low. Nevertheless,
the researchers claimed that these pharmacists actively participate in monitoring medical therapy
and educating patients about the medication (Alsultan, Khurshid, Salamah, Mayet, & Al-jedai,
2012).
Hypertension is a problem and a long-term, chronic problem for those with the disease.
Research also is being done to determine adherence of people with hypertension in Saudi Arabia
by Al-Gelban et al. (2011). The purpose of the research on this issue was to determine the degree
of knowledge of physicians and how well they adhere to the recommendations of clinical
practice guidelines of the Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure (JNC7). To evaluate these events,
the author used “a modified version of the World Health Organization Physician Inquiry
Questionnaire” (Al-Gelban et al., 2011, p. 941). The study included all physicians working at
PHC centers in the region of Aseer in southeast KSA. The results revealed that there were some
instances in which physicians didn’t comply with the JNC7 guidelines while treating and
diagnosing patients with high blood pressure. In fact, the noncompliance rate from almost 25%
to as high as 94%. The researchers reported that these are low numbers and that these physicians
need additional therapeutic instruction and instructional classes on the rules for hypertension
administration.
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In another study, Alotaibi and his colleagues developed a mobile phone intervention Social Hypertension Awareness and Management System (SHAMS) – that aimed to promote the
management and awareness of hypertension among hypertensive patients in Gulf countries,
including Saudi Arabia (Alotaibi et al., 2016). The SHAMS consists of two components namely
patient/healthcare provider component and hypertension management component. The
patient/healthcare provider component consists of a patient unit, a nurse unit, and an admin unit.
The patient unit consists of a mobile phone and a blood pressure monitoring device. The nurse
unit consists of a data management system that enables the nurses to contact and follow up with
their patients in the virtual space. The admin unit performs several tasks such as maintenance,
repair, and other technical tasks. On the other hand, the hypertension management component
consists of a hypertension awareness module and a data mining module. These models provide
patients with knowledge about hypertension and help them predict their health conditions based
on their medical history. The system database server was installed at the computers and
information technology faculty at the University of Tabuk in Saudi Arabia. Nevertheless, no
evaluation or effectiveness of SHAMS was conducted.
Finally, Tourkmani et al. (2012) researched medication adherence for people in a chronic
disease clinic to determine the motivation and knowledge of medication adherence and to assess
their predictors in an ambulatory setting. To determine medication adherence, they did a crosssectional survey of patients that were attending a chronic disease clinic. They used the Modified
Morisky Scale. They interviewed the patients, and most had at least two and sometimes more
chronic disease and were taking 6.3 medications and 6.5 pills per prescription. Adherence
attention was low at only 4.6% (Tourkmani et al., 2012).
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2.11 Readiness of Diabetes and Hypertension Patients to Manage Their Diseases by Using
Mobile Health Applications in Saudi Arabia
The readiness and acceptability of patients and other consumers to use mobile health
applications to receive healthcare services by researchers and healthcare providers in the
developing countries have been evaluated in the literature. Using the Technology Acceptance
Model (TAM), El-Wajeeh and his colleagues investigated the factors that might affect the
acceptance of patients and medical staff from Egypt and Yemen to use mobile health technology
(El-Wajeeh, Galal-Edeen, & Mokhtar, 2014). These factors include, among others, perceived
ease of use, perceived usefulness, patients’ trust in using mobile health services, social influence,
data privacy, and resistance to change. A total of 302 subjects was selected to complete a
questionnaire, including different items that measure the selected factors. The results revealed
that 90% of the respondents intended to use mobile health applications. Also, it was found that
perceived usefulness and social influence have a significant effect on consumers’ intention to use
mobile health applications. Nevertheless, a major limitation of this study is that participants
provided their feedback without experience in using mobile health applications.
In rural Bangladesh, a similar study was carried out to identify the factors that contribute
to patients’ readiness to use mobile health applications (Khatun et al., 2015). A conceptual model
containing three dimensions, namely technological, motivational and resource readiness was
developed. A total of 5152 individuals randomly chosen to complete a questionnaire containing
items of the three dimensions mentioned above. The study indicated that 73% of the subjects
showed an interest in participating in mhealth programs. Moreover, it has been reported that the
perception that mhealth may yield slower treatment comparing to conventional treatment
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procedures was cited as one of the reasons that contribute to a lack of interest in participating in
mhealth applications.
In Puducherry, India, a cross-sectional study was conducted to assess the readiness of
residents to participate in mhealth applications (Reddy, Majella, Selvaraj, Jayalakshmy, & Kar,
2016). The assessment was conducted using interviews, which was designed to measure
residents’ access to a personal mobile phone, knowledge of using mobile phones, including
making and receiving calls and SMS messages, and willingness to use the mobile phone for
healthcare services. A total of 299 individuals were selected to participate in the study using
systematic random sampling. The study reported that more than 42% of the participants know
about using mobile phone features such as calls and SMS. Also, half of the participants were
willing to receive health information via mobile phones.
In Saudi Arabia, few studies explored the acceptability and readiness of patients and
healthcare professionals to use mobile health applications. For instance, Jamal and his colleagues
conducted a cross-sectional study to explore the user experience regarding perception and
attitude towards using mobile phone technology among medical staff for academic and medical
purposes in Riyadh, Saudi Arabia (Jamal et al., 2016). A web-based questionnaire was designed,
and a total of 133 medical specialists were chosen to participate in the study. Factors such as
confidentiality, safety, and access to patients’ information, as well as the challenges of using
mobile phone technology, were investigated. Of the 133 chosen to participate in the study, 101
participants completed the survey leading to a response rate of almost 76%. The results showed
that the majority of the participants believed that healthcare facilities should adopt the use of
mobile phones to share patients’ information, drug references, and medical references.
Moreover, the majority of the participants believed that mobile phone technology should be
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integrated with hospitals’ information systems. Limitations of using the mobile phones that were
reported by the participants included short lifespan of mobile phone battery and using a mobile
phone for nonmedical purposes causing physicians to distract from their work.
Also, Alkhudairi assessed the acceptability of using a mobile phone intervention by
patients, physicians, and specialists to manage diabetes in Saudi Arabia (Alkhudairi, 2016). The
study is comprised of two phases. The first phase aimed to measure perceptions, attitudes, and
living experiences of patients with diabetes by interviewing specialists in diabetes. The second
phase of the study included a questionnaire developed to evaluate patients’ perceptions and
experiences of diabetes. The questionnaire also aimed to measure the feedback of the doctors
who provide treatment of diabetic patients. The findings of the study indicated that both diabetic
patients and physicians provided positive feedback regarding the adoption and use of mhealth
interventions to manage diabetes. The study also reported that culture, age, gender, education
level, income, and location influenced the adoption of such interventions in Saudi Arabia.
Moreover, some limitations, such as lack of direct interaction between the patient and the
physician may affect the successful implementation of mhealth interventions.
In another study, Alajmi and his colleagues conducted a survey to evaluate the level of
awareness and attitude of selected physicians in Al-Dammam, Saudi Arabia (Alajmi et al.,
2015). Factors considered in the study were age, gender, and work experience. The study also
aimed to measure physicians’ perceptions, requirements, and priorities to promote mhealth
interventions in Saudi Arabia. A total of 121 physicians were chosen to be invited to participate
in the survey, 93 of which complete it is leading to a response rate of 77%. The results revealed
that the majority of physicians reported high levels of willingness and preferences towards the
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use of technology in healthcare. Also, physicians’ age and knowledge were found to influence
their willingness to use technology in healthcare practices.
In the same context, Alotaibi (2015) conducted a preliminary study to measure patients’
perception of using mobile phone technology for providing management and knowledge of
fasting diabetes in Saudi Arabia. The study was conducted in two phases. The first phase was
comprised of interviews with physicians to outline the requirements of designing a mobile phone
educational program for fasting diabetes in Saudi Arabia. The second phase included a
questionnaire designed for diabetic patients to measure patients’ perspectives regarding the
educational elements of the program. Specifically, a total of 62 patients, mostly youth, with type
1 and type 2 diabetes and three physicians were recruited in the study. The results revealed that
the majority of the patients (more than 96%) have not participated in any fasting diabetes
educational program, which indicated an urgent desire for such programs. Also, the study
showed that the majority of the patients provided positive feedback on the use of the mobile
phone features such as SMS text messaging and video tutorials to receive fasting diabetes
educational programs (Alotaibi, 2015).
The readiness of patients with diabetes to use mobile phone applications to receive
healthcare services was explored in Saudi Arabia (Alenazia et al.). A Mobile Health Effect and
Readiness Questionnaire (MHERQ) was developed and distributed among a sample of 30
diabetic patients selected to participate in the study. The results revealed that more than twothirds of the participants acknowledged that they would feel healthier and their management of
diabetes would be enhanced using mobile health technology. Moreover, 63% of the patients
surveyed reported that they were willing to send their medical information, such as blood
glucose levels to a physician using mobile phone technology.
76

2.12

Conclusion

After careful review of the above studies, it becomes clear that there was a gab related to
the effectiveness of mobile health technology regarding self-management and diagnostic for
diabetes and hypertension diseases in developing countries and especially in Saudi Arabia see
table 14. The problem was identified by different stakeholders to protect those patients and to
provide them with the best services. Many articles talked about how the intervention of mobile
health technology improved healthcare service with patients in developed countries. There were
very few articles that talked about this subject in developing countries. Therefore, this study will
focus on the effectiveness of mobile health intervention in Saudi Arabia.
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CHAPTER THREE: METHODOLOGY
3.1

Introduction

The purpose of this study was to evaluate the effectiveness of mhealth application
intervention to remind the patients for a doctor appointment, medication adheres and to
managing the number of unnecessary patient’s follow up visits in developing nations. In order to
do so, the researcher arranged to collect the related data from a sample of diabetic hypertriton
patients monitored by various centers at Al-Noor Specialist Hospital in Makkah, Saudi Arabia.
These centers are Diabetes and Endocrine Center, hypertension and kidney center, and internal
medicine center. This section illustrated the methodology applied in this study. The first part
talked about the research hypothesis, which includes the three questions of this study with the
hypotheses for each question and the variables which were analyzed to respond to the research
questions. The second part talked about the mhealth application and intervention, which describe
the application that used in this research and the intervention of mhealth. The third part described
the methodology of this study, including the procedures of sampling, preparation procedures for
nurses and patients, procedures for the experiment and data collection procedures. The last part
of this chapter talked about threats to validity and moral procedures.
3.2 Research Hypothesis
Q1: Does utilizing of refill medication reminder feature of DHA have a positive statistically
significant impact on medication adherence levels of diabetic and hypertension patients in
developing countries?
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Ho1: No, utilizing of refill medication reminder feature of DHA does not have a positive
statistically significant impact on medication adherence levels of diabetic and hypertension
patients in developing countries
Ha1: Yes, utilizing of refill medication reminder feature of DHA has a positive statistically
significant impact on medication adherence levels of diabetic and hypertension patients in
developing countries.
Q2: Does utilizing the pre-appointment checkup feature for the Hemoglobin A1c test has a
positive statistically significant impact on decreasing the number of visits per patient for diabetic
patients in developing countries?
Ho2: No, utilizing the diagnostic feature does not have a positive statistically significant impact
on decreasing the number of visits per patient for diabetic patients in developing countries.
Ha2: Yes, utilizing the diagnostic feature has a positive statistically significant impact on
decreasing the number of visits per patient for diabetic patients in developing countries.
Q3: Does utilizing doctor appointment reminder feature of DHA have a positive statistically
significant impact on adherence to doctor appointments of diabetic and hypertension patients in
developing countries?
Ho3: No, utilizing of doctor appointment reminder feature of DHA does not have a positive
statistically significant impact on adherence to doctor appointment levels of diabetic and
hypertension patients in developing countries.
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Ha3: Yes, utilizing of doctor appointment reminder feature of DHA has a positive statistically
significant impact on doctor appointment levels of diabetic and hypertension patients in
developing countries.
3.2.1

Independent and Dependent Variables

There were three independent variables in this study, namely the refill medication state,
the doctor appointment state, and the Hemoglobin A1c test result. The first variable was the refill
medication state. This variable was a dichotomous variable that has two only values (1) if a
patient was present and (0) if a patient was absent. The second variable was the doctor's
appointment state. This variable was also dichotomous and took only two values (1) if a patient
was present and (0) if a patient was absent. Finally, the third one was the Hemoglobin A1c test
result, which obtained from the analysis center in Al-Noor Hospital. In addition, the study
includes three dependent variables, namely the adherence to refill medication time, adherence to
doctor appointments, and the frequency of clinic visits.
A covariate is a variable which observes during the research or statistical analysis, but
cannot control it, and it is not the focus of the study analysis (Miller & Chapman, 2001). The
covariates were identified in this study were five, and they were based on previous studies in the
same field. The first covariate was the age (Alajmi et al., 2015; Alkhudairi, 2016). Age was the
second question that the patients have to answer it after setting up the application. Age is a ratio
variable calculated by years. The second covariate was weight (Afifi et al., 2015; Al-Hamdan et
al., 2011). Weight was the third question, and it is also a ratio variable that is measured by
kilograms. The third covariate was chronic disease history (Carr et al., 2006; El Bcheraoui et al.,
2014). Chronic disease history was the fourth question and it is a dichotomous variable. The
dichotomous variable is “a nominal variable which has two categories or levels” (Montgomery &
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Runger, 2010). Chronic disease history was obtained from the application for patients who
received mobile health intervention. Any diseases were considered except diabetes for diabetes
patients and hypertension for hypertension patients. The assigned value for no chronic diseases =
(0) and yes if there were chronic diseases =(1).
3.3

Mhealth Application and Intervention

This research measured the effectiveness of mobile health intervention by added three
new features to use it in Diabetes and Endocrine Center and two features to use it in hypertension
and kidney center and internal medicine center at Al-Noor Specialist Hospital in Makkah, Saudi
Arabia. The three new ideas of this study were refilled medication reminders (RMR), managing
the number of follow-up visits and doctor appointment reminders (DAR). These ideas were used
for diabetes patients but for hypertension patients, the first and the third features were used only.
Al-Noor Specialist Hospital in Makkah is one of the essential medical clinics. It was established
in 1989G by order of the king of the Kingdom of Saudi Arabia as a health care hospital to serve
the citizens, residents, and pilgrims of the holy city and surrounding area. It is a public hospital
under the supervision of the Directorate of Health Affairs in Makkah. It is in the heart of the city
near the holy sites (Muzdalifah) and 3.5 km from the Grand Mosque. It has a capacity of 500
beds, and it includes all medical specialties and supported by specialized medical staff to provide
a wide range of services such as general surgery and medical and therapeutic units that provide
other services, including heart disease, intensive care unit and burns (Kaser).
SAED application is a wise versatile diabetes administration and instructive framework
focused on Saudi Arabia. It was set up in 2014 in Medical Information and Network (MINT)
Research Excellence Center at Kingston University, London. It comprises two fundamental
segments. The primary segment was the SAED versatile patient/medicinal services supplier
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segment, which incorporates the diabetic patient unit and expert unit. The second part was SAED
insightful diabetes administration segment which incorporates a SAED database module, a canny
choice help module, SAED SMS update module, and diabetes instructive module figure 7
explains the two components (Alotaibi et al., 2014b).

Figure 7 description the two components (Alotaibi et al., 2014a)
The features of SAED application as follow:
1- “A specific schedule of readings for each diabetic patient set by the diabetic nurse
rather than the patient.
2- Reminding the diabetic patient to send the glucose test readings, blood pressure test
readings, and food intake reports on a schedule.
3- Providing brief feedback on the patient’s status when the patient inserts a reading.
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4- Establishing a sufficient connection between the medical staff and the diabetic patient
using SMS or e-mail.
5- Managing the hypoglycemia via the system without the need for diabetic nurse
intervention, based on the critical time of the hypoglycemic event.
6- Providing the specialist diabetic nurse, the ability to send SMS feedback regarding
blood glucose or blood pressure level readings.
7- Providing the diabetic patient and specialist nurse with a data visualization tool to
display the data in tables and charts.
8- Supporting the specialist nurse with a diabetic decision support system.
9- Supporting the diabetic patient with an educational program.” (Alotaibi et al., 2014b,
p. 2)
DHA application is covering different areas than the SEAD application. Table 15
describes the new features added to the DHA Tracking application.
Table 15 The features that have been created for DHA application
Diseases

Application Features of DHA

Diabetes

Refill medication reminder (RMR)
Doctor appointment reminder (DAR)

Hypertension

Refill medication reminder (RMR)
Doctor appointment reminder (DAR)
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3.4

Methodology

3.4.1 Procedures of Sampling
The sample size of this study comprised of diabetic and hypertensive patients, male and
female, who have visited Al-Noor Specialist Hospital during the period from September 01,
2019, to October 30, 2019. A total of n= (364) patients, 199 of which are diabetic patients and
165 patients of which are hypertension patients, were selected to participate in the study. All
patients were 18 years old or older and had a smartphone with an applicable system to install the
DHA application. The exclusion patients were the prisoners, pregnant, and disabilities patients as
per Institutional Review Board (IRB) agreement.
There were two different groups in this study, which were the diabetes group and the
hypertension group. Both groups received their health care service with mobile health
intervention for 60 days, and the author considered these data as post-intervention data. The preintervention data was collected from the hospital records for each selected patient for 60 days.
The sample of each group was selected based on a stratified random sample approach
depend on demographic information such as gender, age, weight, and the history of patients’
chronic diseases. “A stratified random sample is a population sample that requires the population
to be divided into smaller groups”(Mahardika & Gustomo, p. 627). The comparison will be
between the data for each patient before the intervention and after the intervention.
The sample size was determined based on the sample size formula for discrete data. The
formula of sample size is: n= p*(1-p)*(Z/E)^2 which n is the minimum sample size, p is the
effected percentage of the population or probability of previous similar studies, z value is value
of standard normal distribution and E is the maximum allowable deviation or error of the
estimate (Montgomery & Runger, 2010). For diabetes sample size, p=17.7%, Z value= based on
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confidence level that the researcher chooses which is 95% is 1.96, E= 0.05. The sample size for
the diabetes group is 199. For hypertension sample size, p=34.3%, Z value= based on confidence
level that the researcher chose which is 95% is 1.96, E= 0.05. The sample size for the
hypertension group is 165.
3.4.2

Preparation Procedures for Nurses, And Patients

The author recruited three nurses and medical assistants at Al-Noor Specialist hospital to
assist in the implementation of the mhealth intervention. The team obtained approval from the
ministry of health to implement the mhealth intervention and to collect data from the selected
patients. The mhealth team ensured that patients’ confidentiality, data quality, and assurance
were fully maintained during the data collection period. Patients were approached by the mhealth
team in the waiting rooms and were asked if they would like to participate in the study after
giving them a brief description of the intervention. Patients who agreed to enroll in the study
were then asked to complete and sign a participation form, which includes information such as
permitting to receive notifications from the application reminders regarding medication refill and
doctors’ appointments and permission to get their information from the hospital health record.
3.4.3

Procedures of the experiment

The application consisted of two main features covering the first and third research
questions. The first feature dialed with the refill medication reminder (RMR) process, which was
answered the first question. After the participants completed the registration steps, they were
received a refill medication reminder (RMR) messages. Refill a medication reminder (RMR) is a
feature to remind the participant to refill the medication date. The first message was sent to the
participant three days before the refill date. The content of the message was “Your medication
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refill date will be ready within three days.” A second message was sent to the participant one day
before the medication date. The content of the second message was “Your medication refill date
will be ready tomorrow.” After that, the participant was asked whether or not he or she got the
medication. If the answer was yes, then the participant has received a message for the next refill
medication date. If the answer was no, then the application was sent to the participant reminders
message every day until the participant gets the medication. Subsequently, a new message was
sent to the participant for the next refill date. This process illustrated in the left-hand side of
figure 8.
The second feature of the application dialed with the doctor's appointment reminder
(DAR) process, which answered the third question. After the participants completed the
registration steps, they received a doctor appointment reminder (DAR) messages. A doctor
appointment reminder (DAR) is a feature to remind the participant to adhere to the doctor's
appointment. The first message was sent to the participant three days before the doctor's
appointment date. The content of the message was, “Your doctor appointment will be within
three days.” A second message was sent to the participant one day before the doctor's
appointment. The content of the second message was “Your doctor appointment will be
tomorrow.” After that, the participant was asked whether or not he or she presented to his or her
appointment. If the answer was yes, then the participant received a message for the next doctor's
appointment date. If the answer was no, then the participant asked to enter the new doctor's
appointment date after rescheduled it with a specialized team. The procedures were as illustrated
in the right-hand side of figure 8.
The second research question dialed with managing the number of unnecessary follow-up
diabetic patients. To answer this question first, it is important to know the mechanism of dealing
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with patients in the hospital, which was as followed: (1) a patient will do the cumulative blood
sugar test (Hemoglobin A1c) in the laboratory at the hospital. (2) The results will be entered into
the hospital database under the name of each patient. (3) the doctor will see the participant and
his or her result, then the doctor will determine the participant's condition and give the necessary
treatment and adjust the dose according to the test results. So, to calculate the number of
unnecessary follow-up visits, the exact number of patients without their names or any
information were getting for five different diabetics clinics and got the Hemoglobin A1c test
result for each patient. Then the doctors were met by the principal investigator to see how many
patients should not be seen based on their test result.

Figure 8 explanation of the process for two new features

91

3.4.4

Procedures for Data Collection

Data for this study was obtained in two different ways, the data for questions number one
and three was obtained from the application, and hospital record for diabetic and hypertension
groups, and the research team recorded these data in an excel sheet daily. For the second
question, the data was obtained from the hospital record recorded in the excel sheet, see table 16.
Then the data was converted to Statistical Package for the Social Sciences program (SPSS) to
analyze it. Each variable of this study was assigned a variable name and value. Data such as age,
weight and chronic disease history were used as input data to the developed mobile phone
application. Also, demographic and clinical information were also collected through an
electronic database system. These data were collected by the research team. There were four data
sources for this study. The first source was from the pharmacy section in the hospital, the second
source was from the appointment section, the third source was from the application and the
fourth source was from the health record system.
Statistical Package for the Social Sciences program (SPSS) was used to analyze the data
and aid in the interpretation of the results. Statistical tests such as logistic regression and ChiSquare test were used to determine whether there are significant differences existed between the
pre- and post-intervention and the previous cases regarding managing the number of unnecessary
follow-up visits, the refill medication reminder, and the doctor appointments reminder.
Table 16 The instruments for each question pre-intervention of mobile health application and
after.
No.
Pre MHI
Post MHI
Q1 Does utilizing of refill medication reminder feature of DHA has a positive statistically
significant impact on medication adherence levels of diabetic and hypertension patients
in developing countries?
1
Refill medication reminder (RMR)
Hospital Record
Application
Q2 Does utilizing the pre-appointment checkup feature for Hemoglobin A1c test have a
positive statistically significant impact on decreasing the number of visits per patient for
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2
Q3

3

diabetic patients in developing countries?
Decrease number of visits per patients for the Hospital Record
Hospital
doctor
Record
Does utilizing of doctor appointment reminder feature of DHA has a positive
statistically significant impact on adherence to doctor appointments of diabetic and
hypertension patients in developing countries?
Doctor appointment reminder (DAR)
3.5

Hospital Record

Application

Threats to Validity

The results of the study may be affected by two types of validity, which are internal and
external validity. Internal validity refers to the researcher’s continence of the existence of a
relationship between the independent and the dependent variables. Factors that may threaten the
internal validity, according to Michael (20144), include history, maturation, selection bias, and
mortality. External validity, on the other hand, refers to the researcher’s extent to generalize the
results to other populations (Michael). Both the internal and external validity will be measured
after the implementation of the mhealth intervention
3.6

Ethical Procedures

The mhealth team fully complied with the regulations set by the ministry of health in
Saudi Arabia regarding researching Saudi hospitals. As part of these regulations, the principal
investigator had to obtain approval from the ministry of health to conduct the study at Al-Noor
Specialist Hospital. The approval was obtained from the ministry of health. Consequently, the
team received a letter of permission to conduct the project, communicate with patients, and have
access to medical information records.
Ethical behavior regarding patients’ recruitment process, data collection, and other
relevant intervention activities were fully practiced during the implementation period of the
study. Also, there is no risk to the patients as a result of their participation and use of the refill
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medication reminder and the doctor appointment reminder applications. In coordination with AlNoor Specialist hospital, the mhealth team used different tools to protect patients’
confidentiality. The research team also used patients’ IDs issued by the hospital in the collection
and classification of data.
Based on a meeting with the hospital top management, patients’ demographic and clinical
information were made available to the researcher. Moreover, raw data were also made available
to the researcher only and installed on his personal computer and protected by a login password.
Also, the mhealth team had applied to the Institutional Review Board (IRB) at the
University of Central Florida (UCF) to implement the mhealth intervention in Saudi Arabia to
make “sure that the rights and welfare of human participants involved in the project are
protected” (IRB). As part of the UCF IRB application process, “all Human Research conducted
by UCF faculty, staff, and students must be reviewed by the IRB and approved for compliance
with regulatory and ethical requirements before it may be undertaken” (IRB). Thus, the UCF
IRB application was approved in 2018. Moreover, letters of permission for conducting this study
were obtained from the Saudi ministry of health and at Al-Noor Specialist Hospital and were
included in the UCF IRB application.
In addition, the proposed mhealth intervention was described as a low-risk intervention
by the mHealth team in the UCF IRB application, which means that the participants had a low
risk of adverse events resulting from participating in the project. In fact, the mHealth team used
specific measures to protect patients’ confidentiality as required by the UCF IRB. Once the UCF
IRB approval was received, the mHealth team at Al-Noor Specialist Hospital made the project
data available to the researcher. However, patients’ identities are not made available to the
researcher as required by the UCF IRB.
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CHAPTER FOUR: FINDINGS
4.1

Introduction

The purpose of the study is to evaluate the effectiveness of mhealth intervention for
diabetic and hypertensive patients at Al-Noor Specialist Hospital in Makkah, Saudi Arabia. The
mhealth intervention has two features, namely, refill medication reminder and doctor
appointment reminder. In these features that were built in the mhealth application, a third feature
was investigated in the study, which is managing the number of unnecessary follow-up patients.
The research questions were formulated to assess these three features. The hypotheses were
reported to indicate whether or not statistically significant differences in the level of adherence
exist between the pre- and post-intervention groups.
This chapter starts with a review of the research objective, research questions, and
research hypotheses. This is followed by a detailed description of the research participants and
data collection. A discussion on the analysis of results, which includes descriptive statistics,
testing of covariates, and logistic regression. This is followed by treatment and/or intervention
fidelity. The chapter concludes with a summary of the findings and the introduction to chapter 5.
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4.2

Data Collection

As mentioned in Chapter 3, the data for this study was obtained from the hospital's
database and the application. These data include the demographic information of the participants,
such as age, gender, and weight, and patients' medical history. Patients at Al-Noor Specialist
Hospital refill their medications based on their health status. In this regard, the study period was
divided into two months before the intervention, where patients refill their medication and see
their physicians at least two times, and two months after the intervention, where patients refill
their medication and see their physicians for at least two times. The pre-intervention period
lasted two months starting from August 15, 2019, to October 15, 2019, while the postintervention period lasted for two months starting from October 15, 2019, to December 15, 2019.
The sample sizes for patients with diabetes and hypertension were 199 and 165,
respectively. For diabetic patients, 101 of the 199 were male, and the remaining were female. For
hypertension patients, 82 were male, and the remaining were female. Participants were selected
using a stratified random sampling method where patients stratified based on their gender, age,
weight, and history of chronic diseases.
4.3
4.3.1

Result

Descriptive Statistics

Study Population for diabetes patients:
For diabetes, the study sample size was N = 199 participants of whom n = 98 (49.2%) were
female and n = 101 (50.8%) were male. The demographic and descriptive characteristics of the sample
population are summarized in Table 17 diabetes patients with Refill medication reminder features and
Table 18 diabetes patients with doctor appointment reminder features.
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Diabetes Patients -Refill Medication Reminder (RMR):
Before mobile health intervention: 111 patients in the Adherence group and 88 in the non- Adherence
group
111 in the Adherence group: (female= 53 (48%), male=58 (52%)), (have chronic diseases= 75
(68%). No chronic diseases= 36 (32%)), weight (Mean=85, SD=18.6), age (Mean=41, SD=13),
Height (Mean=166.6, SD=8.7).
88 in the non-Adherence group: (female= 75 (51), male=43 (49%)), (have chronic diseases= 66
(75%). No chronic diseases= 22 (25%)), weight (Mean=84, SD=18.2), Age (Mean=42.4, SD=13.7),
height (Mean=165, SD=8.4).
After mobile health intervention: 155 patients in the Adherence group and 44 patients in the nonAdherence group.
155 patients in the Adherence group: (female= 80 (52%), male=75 (48%)), (have chronic diseases=
46 (30%). No chronic diseases= 109 (70%)), weight (Mean=84.3, SD=18.6), age (Mean=40.7,
SD=13.3), height (Mean=165.8, SD=8.5).
44 patients in the non-Adherence group: (female= 18 (41), male=26 (59%)), (have chronic diseases=
12 (27%). No chronic diseases= 32 (73%)), weight (Mean=86.1, SD=17.7), Age (Mean=45.1,
SD=12.8), height (Mean=165.6, SD=8.8).
Table 17 Characteristics of participants stratified by Adherence status and the remainder
(Diabetes Patients -Refill Medication Reminder) n=199
Characteristics

Without remainder
With remainder
Adherence (n=111) Non-adherence (n=88) Adherence (n=155) non-adherence (n=44)
n(%)
n(%)
n(%)
n(%)

Gender
Female
Male
chronic diseases
Yes
No

53 (48)
58 (52)

45 (51)
43 (49)

80 (51.6)
75 (48.4)

18 (40.9)
26 (59.1)

75 (68)
36 (32)

66 (75)
22 (25)

109 (70.3)
46 (29.7)

32 (72.7)
12 (27.3)
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Weight, Mean (SD)
Age, Mean (SD)
height, Mean (SD)

85 (18.6)
41 (13)
166.6 (8.7)

84.32 (18.2)
42.39 (13.7)
165 (8.4)

84.3 (18.6)
40.7 (13.3)
165.8 (8.5)

86.1 (17.7)
45.1 (12.8)
165.6 (8.8)

Diabetes Patients -Doctor Appointment Reminder (DAR):
Before mobile health intervention: 149 patients in the Adherence group and 50 in the non- Adherence
group.
149 patients in the Adherence group: (female= 70 (47%), male=79 (53%)), (have chronic diseases=
105 (66%). No chronic diseases= 44 (34%)), weight (Mean=85, SD=18), age (Mean=41.3, SD=13.3),
height (Mean=166.1, SD=8.7).
50 patients in the non-Adherence group: (female=28 (56%), male=22 (44%)), (have chronic
diseases= 36 (72.5%). No chronic diseases= 14 (27.5%)), weight (Mean=83.8, SD=19.8), Age
(Mean=42.8, SD=13.2), height (Mean=164.8, SD=8.4).
After mobile health intervention: 170 patients in the Adherence group and 29 patients in the nonAdherence group.
170 patients in the Adherence group: (female= 79 (46.5%), male=91 (53.5%)), (have chronic
diseases= 47 (27.6%). No chronic diseases= 123 (72.4%)), weight (Mean=84.9, SD=18.9), age
(Mean=41.5, SD=13.1), height (Mean=165.4, SD=8.2).
29 patients in the non-Adherence group: (female=19 (65.5%), male=10 (34.5%%)), (have chronic
diseases=18 (62.1%). No chronic diseases=11 (37.9%)), weight (Mean=83.3, SD=15.5), Age
(Mean=42.8, SD=14.5), height (Mean=168, SD=10.6).
Table 18 Characteristics of participants stratified by Adherence status and the remainder
(Diabetes Patients - Doctor Appointment Reminder) n=199
Characteristics

Without remainder
With remainder
Adherence (n=149) Non-adherence (n=50) Adherence (n=170) non-adherence (n=29)
n(%)
n(%)
n(%)
n(%)

Gender
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Female
Male
chronic diseases
Yes
No
Weight, Mean (SD)
Age, Mean (SD)
height, Mean (SD)

70 (47)
79 (53)

28 (56)
22 (44)

79 (46.5)
91 (53.5)

19 (65.5)
10 (34.5)

105 (66)
44 (34)
85 (18)
41.3 (13.3)
166.1 (8.7)

36 (72.5)
14 (27.5)
83.8 (19.8)
42.8 (13.2)
164.8 (8.4)

123 (72.4)
47 (27.6)
84.9 (18.9)
41.5 (13.1)
165.4 (8.2)

11 (37.9)
18 (62.1)
83.3 (15.5)
42.8 (14.5)
168 (10.6)

Managing the number of unnecessary follow-up visits
To manage the number of unnecessary follow-up visits for patients with diabetes, each
patient should perform the Hemoglobin A1c test. If the Hemoglobin A1c level is high, an
appointment with the physician will be scheduled for this patient. If, on the other hand, the
Hemoglobin A1c level is normal, then the patient is directed to a primary care unit to receive
regular care.
To calculate the number of unnecessary follow-up visits, patients visiting five diabetic
clinics were tested for their Hemoglobin A1c level. Based on this test, the percentages of the
unnecessary follow-up visits were calculated for each clinic as shown in the following table.
Table 19 Management of the number of follow up visits for diabetic patients
Number
of
patients
for 30
days

Necessary
follow up

Effective
clinical
appointment
rate

Could be
eliminated

From

To

Clinic 1

422

342

19.91

80

4/72019

5/5/2019

Clinic 2

399

319

20.55

82

3/8/2019

4/6/2019

Clinic 3

198

138

40.91

81

3/8/2019

4/6/2019

Clinic 4

174

94

21.84

38

3/8/2019

4/6/2019

Clinic 5

525

420

20

105

2/7/2019

3/7/2019
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Study Population for hypertension patients:
For hypertension, the study sample size was N=165 patients of whom n=83 (50.3%) were
female, and n=82 (49.7%) were male. The demographic and descriptive characteristics of the sample
population are summarized in Table 20 of hypertension patients with Refill medication reminder
features, and Table 21 hypertension patients with doctor appointment reminder features.
Hypertension Patients -Refill Medication Reminder (RMR):
Before mobile health intervention: 109 patients in the Adherence group and 56 patients in the nonAdherence group.
109 in the Adherence group: (female= 51 (47%), male=58 (53%)), (have chronic diseases= 67
(61.5%). No chronic diseases= 42 (38.5%)), weight (Mean=84.8, SD=17.6), age (Mean=45.4,
SD=13.5), height (Mean=166, SD=8).
56 in the non-Adherence group: (female=32 (57%), male=24 (43%)), (have chronic diseases= 36
(64%). No chronic diseases= 20 (36%)), weight (Mean=83, SD=19), Age (Mean=43, SD=12), height
(Mean=167, SD=8.1)..
After mobile health intervention: 158 patients in the Adherence group and 7 patients in the nonAdherence group.
158 patients in the Adherence group: (female=79 (50%), male=79 (50%)), (have chronic diseases=100
(63.3%). No chronic diseases=58 (36.7%)), weight (Mean=84, SD=18.3), age (Mean=44, SD=12.4),
height (Mean=166.4, SD=8.3).
7 patients in the non-Adherence group: (female=4 (57%), male=3 (43%)), (have chronic diseases=3
(43%). No chronic diseases=4 (57%)), weight (Mean=83.3, SD=12), Age (Mean=55.6, SD=20.9),
height (Mean=166.3, SD=6.5).
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Table 20 Characteristics of participants stratified by Adherence status and remainder
(Hypertension Patients -Refill Medication Reminder) n=165
Characteristics

Without remainder
With remainder
Adherence (n=109) Non-adherence (n=56) Adherence (n=158) non-adherence (n=7)
n(%)
n(%)
n(%)
n(%)

Gender
Female
Male
chronic diseases
Yes
No
Weight, Mean (SD)
Age, Mean (SD)
height, Mean (SD)

51 (47)
58 (53)

32 (57)
24 (43)

79 (50)
79 (50)

4 (57)
3 (43)

67 (61.5)
42 (38.5)
84.76 (17.6)
45.4 (13.5)
166 (8)

36 (64)
20 (36)
83 (19)
43 (12)
167 (8.1)

100 (63.3)
58 (36.7)
84 (18.3)
44 (12.4)
166.4 (8.3)

3 (43)
4 (57)
85.3 (12)
55.6 (20.9)
166.3 (6.5)

Hypertension Patients -Doctor Appointment Reminder (DAR):
Before mobile health intervention: 102 patients in the Adherence group and 63 patients in the nonAdherence group.
102 patients in the Adherence group: (female= 50 (49%), male=52 (51%)), (have chronic diseases= 63
(61.8%). No chronic diseases= 39 (38.2%)), weight (Mean=85.6, SD=18.3), age (Mean=45.9,
SD=13.5), height (Mean=166.3, SD=8.1).
63 patients in the non-Adherence group: (female=33 (52.4%), male=30 (47.6%)), (have chronic
diseases= 40 (63.5%). No chronic diseases= 23 (36.5%)), weight (Mean=81.6, SD=17.4), Age
(Mean=42.4, SD=12.1), height (Mean=166.4, SD=8.5).
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After mobile health intervention: 139 patients in the Adherence group and 26 patients in the nonAdherence group.
139 patients in the Adherence group: (female=70 (50.4%), male=69 (49.6%)), (have chronic
diseases=85 (61.2%). No chronic diseases=54 (38.8%)), weight (Mean=84.3, SD=18.43), age
(Mean=44.6, SD=13), height (Mean=166.2, SD=8.3).
26 patients in the non-Adherence group: (female=13 (50%), male=13 (50%)), (have chronic
diseases=18 (69.2%). No chronic diseases=8 (30.8%)), weight (Mean=83.1, SD=16.4), Age
(Mean=44, SD=13.3), height (Mean=167, SD=6.5).
Table 21 Characteristics of participants stratified by Adherence status and the remainder
(Hypertension Patients -Doctor Appointment Reminder) n=165
Without remainder
With remainder
Adherence (n=102)Non-adherence (n=63) Adherence (n=139)Non-adherence (n=26)
n(%)
n(%)
n(%)
n(%)

Characteristics
Gender
Female
Male
chronic diseases
Yes
No
Weight, Mean (SD)
Age, Mean (SD)
height, Mean (SD)

4.3.2

50 (49)
52 (51)

33 (52.4)
30 (47.6)

70 (50.4)
69 (49.6)

13 (50)
13 (50)

63 (61.8)
39 (38.2)
85.6 (18.3)
45.9 (13.5)
166.3 (8.1)

40 (63.5)
23 (36.5)
81.6 (17.4)
42.4 (12.1)
166.4 (8.5)

85 (61.2)
54 (38.8)
84.3 (18.4)
44.6 (13)
166.2 (8.3)

18 (69.2)
8 (30.8)
83.1 (16.4)
44 (13.3)
167 (6.5)

Testing of Covariates and Logistic Regression Analyses

Analysis for diabetes patients -refill medication Reminder
Logistic Regression. The first logistic regression for diabetes patients dialed with the
refill Medication Reminder feature was conducted with regards to the dependent variable of
adherence. Variables: intervention, gender, chronic diseases, weight, age, height were included in
the regression model. The results from the logistic regression are presented in Table 22. The
model chi-square was significant, χ² (6, N = 199) = 28.544, p=0.000 < .001, indicating that the
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independent and/or covariate variables significantly predicted adherence at diabetes patients
dialed with RMR. The non-significance of the Hosmer and Lemeshow chi-square test indicated
that the model adequately fit the data, χ² (8) = 10.614, p = 0.225.
The classification table output for model 0 (the model without the various predictor
variables) correctly classified 66.8% of adherence. In comparison, the classification table for
model 1 (which included the various predictor variables) indicated that correctly classified
67.3% of adherence. There was a minimal difference in the classification tables between model 0
and 1. The Nagelkerke R2 indicated a 7.0% variance in the model.
One variable (Intervention) significantly predicted (p < .001) in the dependent variable
(adherence), where (B=1.044, odds ratio Exp(B)=2.84 CI 95%(1.829-4.41), p=0.000) indicates if
there was Intervention, so the adherence increases 2.84 times more than without Intervention.
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Table 22 Diabetes Patients-Refill Medication Reminder: Intervention and Predictor Variables for
adherence (N = 199) according to logistic regression analysis
95% CI for EXP(B)
B
Constant

S.E. Wald

p

Exp(B)
Lower

Upper

-2.202

2.193 1.009

.315

.111

.068

.222 .092

.761

1.070

.692

1.654

-

-

-

-

.429

.821

.503

1.339

-

-

-

-

1.829

4.413

Gender
Female
Male

-

-

-

chronic diseases
Yes

-.198

NO

-

.250 .627
-

-

Intervention
Yes

1.044

No

-

.225 21.580 .000*** 2.84
-

-

-

-

-

-

Weight

-.001

.007 .013

.910

.999

.986

1.013

Age

-.016

.009 3.071

.080

.984

.967

1.002

height

.020

.014 1.996

.158

1.020

.992

1.048

χ²

28.544***

df

6

Correct Classified 67.3%

Note: ***p < .001.
Analysis for Diabetes Patients -Doctor Appointment Reminder
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Logistic Regression. The first logistic regression for diabetes patients dialed with doctor
appointment reminder feature was conducted with regards to the dependent variable of
adherence.
Variables: intervention, gender, chronic diseases, weight, age, height were included in the
regression model. The results from the logistic regression are presented in Table 23. The model
chi-square was significant, χ² (6, N = 199) = 14.7, p=0.023<.05, indicating that the independent
and/or covariate variables significantly predicted adherence at diabetes-visiting the patient. The
non-significance of the Hosmer and Lemeshow chi-square test indicated that the model
adequately fit the data, χ² (8) = 6.76, p = .563.
The classification table output for model 0 (the model without the various predictor variables)
correctly classified 80.2% of adherence. In comparison, the classification table for model 1
(which included the various predictor variables) indicated that correctly classified 80.3% of
adherence. There was a minimal difference in the classification tables between model 0 and 1.
The Nagelkerke R2 indicated 6.0% variance in the model
Two variables significantly predicted (p < .05) in (diabetes-Refill the medicine).
Intervention variable was significant (B=.690, odds ratio Exp(B)=1.994, p=0.008) indicates if
there is Intervention so the adherence increases 1.99 times more than without Intervention. The
gender variable was significant (B=.558, odds ratio Exp(B)=1.747, p=0.032) indicates if the
patient was female so the adherence increases 1.75 times more than male.
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Table 23 Diabetes Patients -Doctor Appointment Reminder: Intervention and Predictor Variables
for adherence (N = 199) according to logistic regression analysis
95% CI for EXP(B)
B
Constant

S.E.

Wald

p

Exp(B)
Lower

Upper

.349

2.509

.019

.889

1.417

.558

.261

4.584

.032*

1.747

1.048

2.912

-

-

-

-

-

-

-

Yes

.436

.275

2.511

.113

1.546

.902

2.651

NO

-

-

-

-

-

-

-

Yes

.690

.262

1.194

3.329

No

-

-

-

-

-

-

-

Weight

-.004

.008

.226

.634

.996

.981

1.012

Age

-.009

.011

.738

.390

.991

.971

1.012

Height

.005

.016

.109

.741

1.005

.974

1.037

χ²

14.7*

df

6

Gender
Female
Male
chronic diseases

Intervention

Correct Classified

6.955 .008** 1.994

80.2%

Note: * p < .05, ** p < .01, ***p < .001.
Analysis for hypertension Patients -Refill Medication Reminder:
Logistic Regression. The first logistic regression for hypertension patients dialed with a refill
medication reminder feature was conducted with regards to the dependent variable of adherence.
Variables: intervention, gender, chronic diseases, weight, age, height were included in the
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regression model. The results from the logistic regression are presented in Table 24. The model
chi-square was significant, χ² (6, N = 165) = 55.025, p=0.000<.001, indicating that the
independent and/or covariate variables significantly predicted adherence at hypertension patients
dialed with RMR feature. The non-significance of the Hosmer and Lemeshow chi-square test
indicated that the model adequately fit the data, χ² (8) = 6.763, p = .562.
The classification table output for model 0 (the model without the various predictor
variables) correctly classified 80.9% of adherence. In comparison, the classification table for
model 1 (which included the various predictor variables) indicated that correctly classified
80.9% of adherence. There was a clear difference in the classification tables between model 0
and 1. The Nagelkerke R2 indicated a 24.7% variance in the model.
One variable (Intervention) significantly predicted (p < .05) independent variable
(adherence), where (B=2.469, odds ratio Exp(B)=11.807, p=0.000) indicates if there was
Intervention, so the adherence increases 11.8 times more than without Intervention.
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Table 24 hypertension patients-refill medication reminder feature: Intervention and Predictor
Variables for adherence (N = 165) according to logistic regression analysis
95% CI for EXP(B)
B
Constant

S.E.

Wald

p

Exp(B)
Lower

Upper

3.125

3.153

.982

.322

22.756

-.384

.308

1.554

.213

0.681

.372

1.246

-

-

-

-

-

-

-

Yes

-.009

.316

.001

.978

0.991

.534

1.841

NO

-

-

-

-

-

-

-

Yes

2.469

.421

5.171

26.959

No

-

-

-

-

-

-

-

Weight

.007

.010

.461

.497

1.007

.988

1.026

Age

-.001

.013

.006

.940

.999

.974

1.024

Height

-.017

.020

.696

.404

.984

.946

1.023

Gender
Female
Male
chronic diseases

Intervention

χ²

55.025***

df

6

34.342 .000*** 11.807

Correct Classified 80.9%

Note: * p < .05, ** p < .01, ***p < .001.
Analysis for hypertension Patients -Doctor Appointment Reminder:
Logistic Regression. The first logistic regression for hypertension patients dialed with doctor
appointment reminder (DAR) feature was conducted with regards to the dependent variable of
adherence. Variables: intervention, gender, chronic diseases, weight, age, height were included in
the regression model. The results from the logistic regression are presented in Table 25. The
model chi-square was significant, χ² (6, N = 165) = 25.73, p=0.000<.05, indicating that the
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independent and/or covariate variables significantly predicted adherence at hypertension patients
dialed with DAR. The non-significance of the Hosmer and Lemeshow chi-square test indicated
that the model adequately fit the data, χ² (8) = 6.39, p = .604.
The classification table output for model 0 (the model without the various predictor
variables) correctly classified 73.0% of adherence. In comparison, the classification table for
model 1 (which included the various predictor variables) indicated that correctly classified
73.3% of adherence. There was a minimal difference in the classification tables between model 0
and 1. The Nagelkerke R2 indicated a 10.9% variance in the model.
One variable (Intervention) significantly predicted (p < .05) independent variable
(adherence), where (B=1.21, odds ratio Exp(B)=3.354, p=0.000) indicates if there was
Intervention, so the adherence increases 3.35 times more than without Intervention.
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Table 25 hypertension patients- doctor appointment reminder (DAR): Intervention and Predictor
Variables for adherence (N = 165) according to logistic regression analysis
95% CI for EXP(B)
B
Constant

S.E.

Wald

p

Exp(B)
Lower

Upper

1.937

2.696

.516

.472

6.938

.055

.260

.045

.832

1.057

.635

1.760

-

-

-

-

-

-

-

Yes

-.194

.271

.511

.475

.824

.485

1.401

NO

-

-

-

-

-

-

-

Yes

1.210

.269

1.979

5.683

No

-

-

-

-

-

-

-

Weight

.008

.008

1.010

.315

1.008

.992

1.025

Age

.012

.011

1.147

.284

1.012

.990

1.034

Height

-.016

.017

.841

.359

.985

.952

1.018

Gender
Female
Male
chronic diseases

Intervention

χ²

25.73***

df

6

20.223 .000*** 3.354

Correct Classified .733%

Summary of participants' performance presented in table 26. Refill medication reminder
feature for diabetic patients was improved by 22% and 10% improvement for doctor appointment
reminder feature. Also, the Refill medication reminder feature for hypertension patients was improved
by 30% and 22% improvement for doctor appointment reminder feature.
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Table 26 Summary of Participants Performance
Diabetic patients

Hypertension patients

Before
intervention

After
intervention

Before
intervention

After
intervention

N (%)

N (%)

N (%)

N (%)

Refill medication reminder

111 (56%)

155 (78%)

109 (66%)

158 (96%)

Doctor appointment reminder

149 (75%)

170 (85%)

102 (62%)

139 (84%)

4.4

Treatment and/or Intervention Fidelity

The validity of the study was evaluated before and after the intervention. The study was
conducted as planned, and no dropout or lack of interest of the participants were registered
during the study period. However, given the fact that all participants had to use the refill
medication reminder and the doctor appointment reminder simultaneously, it was difficult to
identify which of the two features were responsible for the improvement in the adherence level.
Furthermore, the selection of the participants may pose a threat to internal validity.
4.5

Summary

In response to the research questions, it can be asserted that there is sufficient evidence
indicating that the refill medication reminder and the doctor appointment reminders have a
significant effect on the medication adherence level of patients with diabetes and hypertension.
In addition, the pre-appointment checkup feature for Hemoglobin A1c test was found to reduce
the number of unnecessary follow-up visits for patients with diabetes. Regression analyses were
conducted for the refill medication reminder and the doctor appointment reminder and revealed
that the intervention significantly increased the adherence level for both patients with diabetes

111

and hypertension. For covariate variables, the only gender showed a significant effect on the
doctor appointment reminder for diabetic patients.
The next chapter starts with a discussion of the results. This is followed by conclusions
which were drawn from the study findings. The chapter concludes with limitations of the study,
recommendations for future research, and implications for social change.
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CHAPTER FIVE: DISCUSSIONS & CONCLUSIONS
5.1

Introduction

The purpose of this study was to evaluate the effectiveness of mobile health applications
to manage the behavior of diabetic and hypertension patients based on doctor appointment
adherence and refill medication adherence by using mobile health applications. In addition,
managing unnecessary follow-up visits for them. The three axes of this research were covered by
mobile health applications and patient’s hospital records. Doctor appointment reminder (DAR)
and refill medication reminder (RMR) were covered by mobile health application named (DHA
Tracking). The third axis was covered by the patient’s hospital record and blood sugar level test
(Hemoglobin A1c).
This chapter starts with the interpretation of the findings, including findings in the
context of the theoretical framework. This is followed by the limitations of this study and then
recommendations. The recommendation will include a recommendation for future study. Last
but not least, the implication will be covered including positive social change and the last will be
the conclusion.
5.2

Interpretation of the Findings

The study results indicated that the diabetes-refill was significant (p < .001) on the
adherence level. The descriptive statistics for diabetes-refill showed that only 50 of the
participants adhered to refill medication before the intervention compared to 155 adhered to refill
medication after the intervention. This indicated that the refill medication features helped 105 of
the participants, which is more than half of the sample, adhere to the refill medication. In other
words, the intervention increased the adherence level more than ten times. Other variables, such
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as gender, chronic diseases, weight, age, and height showed no significant effect on the
adherence level of medication refill for patients with diabetes.
The results for diabetes-visiting the patient showed that it has a significant effect
(p=0.023) on the adherence level. The descriptive statistics for diabetes-visiting the patient
showed that the number of participants before the intervention was 149, while the number of
participants after the intervention was 170. This means that the doctor's appointment reminder
feature of the intervention helped 21 patients adhere to their appointments. In addition, gender
has also been found to have a significant effect on the adherence level with female participants
being 1.75 more complied with appointment than male participants.
The results for managing the number of follow-up patients also showed significant
improvement. As discussed in chapter 4, the study examined five clinics to determine the number
of unnecessary follow-up visits of diabetic patients within one month based on their Hemoglobin
A1c level. It was found that the percentage of follow up visits that could be eliminated ranged
from nearly 20% to almost 40%. Such an action would increase the efficiency of the clinic and
increase the number of new patients who could be seen by a physician in a specified period.
For hypertension, the results for the pressure-refill revealed that the model is significant
(p < .001), meaning that the refill medication reminder feature of the mobile application has a
significant effect on the adherence level. Also, the descriptive statistics for pressure-refill showed
that the number of participants increased from 51 before the intervention to 158 after the
intervention, which represents a threefold increase.
The results for pressure-visiting the patient showed that the model is significant (p <
.001), meaning that the doctor appointment reminder feature of the mobile application has a
significant level on the adherence level. Gender was also found to have a significant effect on the
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adherence level. The descriptive statistics for pressure-visiting the patient revealed that the
number of participants increased from 102 before the intervention to 139 after the intervention,
which represents a considerable improvement. Other variables, such as gender, chronic disease,
weight, and age showed no significant effect on the adherence level.
This study reinforces the evidence in the literature regarding the effectiveness of using mhealth
platforms to promote medication adherence for patients with diabetes and hypertension. In
specific, this study agrees with the results obtained by (Alotaibi et al., 2016), in which the
authors examined the effectiveness of using a mobile health application - SAED to manage and
educate diabetic patients in Tabuk, Saudi Arabia. The study found a significant decrease in the
blood sugar of the participants in the intervention group.
5.2.3

Findings in the Context of the Theoretical Framework

As reported in Chapter 2, the theoretical framework of this study was formulated to
investigate the factors that contribute to medication adherence for patients with diabetes and
hypertension. Also, the literature identifies a gap in the studies that examined the effectiveness of
using mhealth to promote adherence to medication and appointment reminders for patients with
diabetes and hypertension. Few studies evaluated the effectiveness of mhealth platforms to
management and treatment of patients with diabetes, while no studies evaluated the use of
mhealth models to manage and treat patients with hypertension in Saudi Arabia. This study
meets this gab as it was conducted to evaluate the effectiveness of mhealth applications in
providing care and treatment for patients with diabetes and hypertension in Saudi Arabia.
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5.3

Limitations of the Study

There were many limitations to this study. One of these limitations was the redness of the
patients to use technology. Principle investigator and the team met around a thousand patients
totally for two months. Patients who interact with the app were few which is 364 compared to
approximately a thousand patients. Many patients were interested in using technology, especially
the youngest patients, but some of them did not know how to use a smartphone or did not have
one. Some patients were living alone and had no one to help them. Helpers such as sons,
daughters, or nurses who help an old patient were not willing to interact with the app because
they considered as extra work. Some old patients had vision problems, and this is one of the
critical limitations of this study.
Another limitation of this study was that only a quantitative method was used in this
study to measure the effectiveness of DHA features. A mixed method of quantitative and
qualitative inquiries would yield accurate results as some variables such as participants' behavior
can only be explained by using the qualitative methods.
Another limitation of this study was the environment. The environment in which the team
worked was not encouraging due to several factors. For instance, the refill medication process
was difficult to track as no records were found in the hospitals or the primary care centers to
know the time and frequency of the refill medication process. Also, many patients had some time
two or more appointments per visit.
Another limitation was the cost of the application. Creating or Developing a mobile
health application is very costly. Indeed, the cost of the application increases with the addition of
new features. It should be noted that the author paid for the application from his own pocket
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money without support from any organizations. This issue should be taken into consideration
when designing future mhealth applications.
Another limitation was collecting data for the refill medication feature for diabetic and
hypertension patients. Some patients were taking their medication from the hospital and some of
them were talking their medication from primary health care and some of them could not find
their medication, so they bought it, and that was giving the team a hard time to check the hospital
record and first primary care to find out if the patients were adherence with medication refill or
no.
Another limitation was the quality of the data. The data were not of a high quality due to
large variations in hospital records. Also, some of the data were missing, and some of them
lacked significant elements. A great deal of effort was achieved by the research team to review
the data and inquire about any errors or missing elements. In the case of missing elements in the
hospital database, for instance, the team manually reviewed the documents and relevant files to
double-check any inquiries and ensure that the data have a minimum number of errors.
5.4
5.4.1

Recommendations

Recommendations for Further Study

Based on the results obtained in the study, a few recommendations could be noted. The
addition of a survey or questionnaire to the participants to know the motive, readiness, and
interest in their participation in the intervention. It may also include items to identify which of
the application components were most useful to the participants and which need more
improvement. This may include feedback on the content and frequency of the reminders.
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Another element that may be considered in future studies is to expand the scope of the
study to other areas. The rural areas of Saudi Arabia, where a large proportion of the population
resides, lack the resources for efficiently providing care and treatment for patients with chronic
diseases. Thus, introducing a study like this one in the area will assist patients with chronic
diseases to manage their health conditions and adhere to medications and doctor appointments.
Also, the extension of the study period could be considered in future studies. For
instance, the pre-intervention period could be extended to six months or one year, while the postintervention period could be increased to one or two years. This will allow the study team to
observe the behavior of the participants over a long period of time and to what degree the
participants continue to use the mhealth application.
Adding a diagnostic feature to the app is also another element that can be considered in
future studies. Controlling and managing chronic diseases, such as diabetes and hypertension are
very important. However, preventing these diseases and providing awareness to the public about
these diseases and their risk factors have the same importance. According to the literature
provided in Chapter 2, few studies focused on the design and implementation of mhealth for
diagnosing purposes. Thus, including a diagnostic feature in future mhealth intervention may
contribute to the current evidence on the effectiveness of mhealth application.
5.5
5.5.1

Implications

Positive social change

This study has a positive impact on social change at various levels. At the individual
level, the intervention proved to be an effective tool in assisting patients with diabetes and
hypertension adhere to their treatment by reminding them to refill their medication and to show
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up for their doctor appointments. According to the study team, the participants showed
willingness and readiness to participate in the intervention and use the mobile application for
managing their diseases. This behavior is supported in the literature as other studies stated that
most of the participants in those studies support the use of mobile phone applications to provide
healthcare services, and they showed motivation and commitment to participate in such an
intervention.
Also, this study has benefits at the family level. If an individual within the family used
mhealth applications, this would encourage other family members with chronic diseases to use
mhealth technology. On the organizational level, this study can lead to improving the quality of
healthcare services provided within the community. As reported in the results, the third feature of
the intervention was designed to manage the number of unnecessary follow-up visits, and it was
successful in reducing the number of unnecessary visits in almost 20% of the situations. Such
action will increase the efficiency of the hospitals and provide a chance for other new patients to
schedule appointments with their physicians.
As in many countries, many patients fail to show up for their appointments. As large as
30% of the patients in Saudi Arabia miss their appointments for different reasons, such as
difficulty in reserving an appointment and forgetting the time of the appointment (Alhamad,
2013a). Adopting a mhealth intervention such as DHA can resolve the issue of missing
appointments by providing the patients with the opportunity to schedule their appointments and
remind them of their appointments a few days before the appointment time. Moreover, the results
of this study reported a significant increase in the number of participants adhering to their doctor
appointments.
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5.6

Conclusion

The study reviewed the literature on the implementation of mhealth technology in the
developing countries focusing on Saudi Arabia. Some of the studies reviewed investigated the
use of SMS text messages to promote medication adherence of patients with chronic diseases
such as diabetes and hypertension. Other studies explored the trends, opportunities and
challenges of mhealth. Also, other studies investigated the readiness of patients and medical staff
to use mhealth application using the Technology Acceptance Model. In addition, other studies
adopted mhealth technology to provide management and education for patients with type 2
diabetes. This study introduced mhealth intervention for patients with diabetes and hypertension
in Saudi Arabia. The proposed included new features such as RMR and DAR.
This study aimed to evaluate the effectiveness of mhealth intervention to provide care
and treatment to patients with diabetes and hypertension in Saudi Arabia. The proposed
intervention was designed to provide three features, namely, the refill medication reminder, the
doctor appointment reminder, and managing the number of follow up visits. The study was
conducted at Al-Noor Specialist Hospital in Mecca, Saudi Arabia, during the period from July 15
to Sep. 15 of 2019. The number of participants in the study was 199 and 165 for diabetes and
hypertension, respectively. The proposed intervention was found to have a significant effect on
the adherence level for medication refill and doctor appointment reminders. Also, the
intervention was efficient in reducing the number of unnecessary follow-up visits. Through the
literature, evidence was found on the effectiveness of mhealth technology, specifically mobile
phone applications in promoting medication adherence to patients with chronic diseases such as
diabetes and hypertension. Also, these applications have a positive social impact on the
individuals, healthcare providers, and the community at large.
120

The proposed mhealth intervention was validated in terms of its effectiveness in
supporting self-management for patients with diabetes and hypertension. It has been found that
patients who used the mhealth intervention showed significant increase in their adherence level
to their medication and appointments with their physicians. Specifically, the refill medication
reminder improved adherence for patients with diabetes and hypertension by 22% and 30%,
respectively. Also, the doctor appointment reminder increased the adherence for patients with
diabetes and hypertension by 10% and 22%, respectively. Thus, it is evident that the proposed
mhealth intervention was successful in enhancing the service delivery to patients with diabetes
and hypertension.
The healthcare systems in most of the developing countries is suffering from a lack of
medical resources such as physicians and nurses, lack of financial resources, and lack of IT
infrastructure. These challenges caused many patients, especially those with chronic diseases, to
struggle when seeking healthcare services. The use of mobile technology to provide healthcare
services solved many of the problems that patients and healthcare providers face. In today’s
world, it is very uncommon to find an individual who does not own a cell phone or has no access
to the internet. Thus, using mhealth technology facilitates patients’ access to healthcare services
and support them in managing their diseases. This will also improve the quality of healthcare
services and increase the patients’ satisfaction.
Research on the adoption of mhealth technology to provide healthcare services in Saudi
Arabia is scant. Most of these studies focused on the use of mhealth to areas such as improving
healthcare services in the emergency department, improving dental care services, assisting
patients with special needs, and promoting disease prevention for obese children, diabetes, and
hypertension. In addition, the majority of these studies have not explored the effectiveness of
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mhealth in promoting adherence to patients with diabetes and hypertension. Moreover, previous
studies have not examined the use of mhealth to provide health services for patients with
hypertension. This study is the first study in Saudi Arabia that focused on providing and
managing information to hypertensive patients by using a mobile health application. Thus, this
study contributes to the body of knowledge on mhealth by in investigating the effectiveness of
mhealth in increasing adherence to medication and doctor appointments for diabetic and
hypertensive patients in Saudi Arabia.
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Consent Form in English Language

Consent Form
Title of research study: Mobile Health Technology to Enhance Healthcare Service Delivery
in Developing Nations (Saudi Arabia)
Investigator: Nawaf Khan
Faculty Advisor: Dr. Pamela McCauley
Key Information
Why am I being invited to take part in a research study?
We invite you to take part in this research study because you are a patient over the age of 18 with
diabetes or hypertension. We want to improve your skills in managing your chronic diseases
such as diabetic and hypertension. The idea of the study, which is being applied for the first time
in Saudi Arabia, is to remind patients of dates for medication refills and doctor appointments by
mobile health application.
Why is this research being done?
The mobile health (mhealth) is defined as the use of cell phone and wireless technologies to
provide medical care services. We are hoping to enhance the effectiveness of mobile health
platforms in developing nations for diabetes and hypertension diseases through managing
patients’ adherence to medication refill schedule. Also, we are hoping to manage patients’
reminder of physicians’ appointments. In addition, we hope to manage the number of
unnecessary follow-up patient visits.
How long will the research last, and what will I need to do?
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You will be in this study for two months. You will need to upload an application to your IOS
device and you will interact with the application for 3 minutes weekly. At beginning, you will
enter dates for your medication refill and doctor appointments. Then you will answer if you
attended them or not.
Is there any way of being in this study could be bad for me?
The risks to you are minimal and do not exceed the risks associated with activities found in daily
life.
Is Will in this study help me anyway?
There are no benefits to you from your taking part in this research. We cannot promise any
benefits to others from your taking part in this research. However, possible benefits to others
include helping you to manage your hypertension or diabetes.
What happens if I do not want to be in this research?
Participation in research is entirely voluntary. You can decide to participate or not participate.
Your decision to participate or not participate will have no impact on your continued medical
care or treatment.
Detailed Information: The following is more detailed information about this study in addition
to the information listed above.
What should I know about a research study?
•

Someone will explain this research study to you.

•

Whether or not you take part is up to you.

•

You can choose not to take part in.

•

You can agree to take part and later change your mind.

•

Your decision will not be held against you.
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•

You can ask all the questions you want before you decide.

Who can I talk to?
If you have questions, concerns, or complaints, or think the research has hurt you, talk to the
research team at (+966)5555-45359 or nawwaf_5000@hotmail.com or faculty advisor: Dr.
Pamela McCauley at +1(407)567-3493 or Pamela.McCauley@ucf.edu
This research has been reviewed and approved by an Institutional Review Board (“IRB”). You
may talk to them at 407-823-2901or irb@ucf.edu if:
•

Your questions, concerns, or complaints are not being answered by the research team.

•

You cannot reach the research team.

•

You want to talk to someone besides the research team.

•

You have questions about your rights as a research subject.

•

You want to get information or provide input about this research.

How many people will be studied?
The study will include up to 350 participants. The maximum number of participants who have
diabetes will be 200, and the maximum number of participants who have hypertension will be
170.
What happens if I say yes, I want to be in this research?
This research will be conducted at Al-Noor Specialist Hospital in Makkah, Saudi Arabia. The
procedures of this research include:
1.

The researchers will check your eligibility for the study:

•

You must have diabetes or hypertension,

•

You must be 18 years of age or older

•

You must have an IOS mobile device to install the application
131

•

Persons who are pregnant, prisoners, cognitively impaired adults, or do not have the

eligible device to set up the application cannot be in this study.
2.

You will sign this consent form, which includes permission to access to your health

record to record if you attended your appointments and your medication refill dates.
3.

You will be instructed to install the application from the Apple Store and will be shown

how to use the application.
4.

You will be asked to provide demographic and medical information about you, which are

your name, age, gender, medical history, weight, height, and medical record number. There will
be no photos or videos required.
5.

Then, you will be asked to enter the dates for your medication refills and doctor

appointments in the app.
6.

After that, you will interact with the application for two months. The app will send you

reminders about your medication refills or doctor appointments and you will be asked to record
when you get your medication or attend the doctor appointment. The investigator will receive
data from the app during the 2 months that you are using it. You will be asked to remove the app
after 60 days of using it.
What are my responsibilities if I take part in this research?
If you take part in this research, you will be requested to interact with the mhealth application in
regard to your doctor’s appointments and medication refill related activities during the twomonth period of the study. Also, you will be asked to grant the principal investigator or his team
the access to your medical record to extract data related to your adherence to doctor’s
appointments and medication refill dates for two months that preceded the study period. That
means we will also ask for access to your medical record to record if you attended your
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appointments and your medication refill dates.
What happens if I say yes, but I change my mind later?
You can leave the research at any time it will not be held against you.
Is there any way of being in this study could be bad for me? (Detailed Risks)
The risks to participants are minimal and do not exceed the risks associated with activities found
in daily life.
What happens to the information collected for the research?
Efforts will be made to limit the use and disclosure of your personal information, including
research study and medical records, to people who need to review this information. Your
personal health information will be secured in an encrypted file, and only the organizations may
inspect and copy your information, which includes the IRB and other representatives of this
organization. The data that will be extracted from your medical record by the principal
investigator will be used for comparison purposes to assess the effectiveness of the utilized
mhealth app in achieving the study stated objectives. Excluding your name, the data that will be
entered by you in the application (i.e. age, gender, medical history, weight, and height) will be
used for statistical analysis and stratification purposes. Federal law provides additional
protection of your medical records and related health information. Saudi Ministry of Health will
be allowed to inspect the research records based on the approval that we got it from them.
However, any other local committee you will need to get approval to be allowed to inspect the
research records. We will also ask for access to your medical record, to record if you attended
your appointments and your medication refill dates.
Can I be removed from the research without my OK?
We will tell you about any new information that may affect your health, welfare, or choice to
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stay in the research.
Data Management and Confidentiality
The data will be saved in a secure excel sheet, and no one can access that data except the
principal investigator. The identifiable data will be destroyed as soon as possible after analysis,
and de-identified data must be held for five years after the closing of the research. The data will
be saved in a secure excel sheet, and no one can access that data except the principal
investigator. The app will not access to any other information, and you will be asked to remove
the app after 60 days of using it.
Signature Block for Capable Adult
Your signature documents your permission to take part in this research and for us to access your
medical records.

Signature of subject

Date

The printed name of the subject

Signature of the person obtaining consent

Date

The printed name of the person obtaining consent

My signature below documents that the information in the consent document and any other
written information was accurately explained to and understood by, the subject and that consent
was freely given by the subject.
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Signature of witness to the consent process

Date

The printed name of the person witnessing consent process
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Consent Form in Arabic Language

خطاب التزام

عنوان الدراسة البحثية :تكنولوجيا الصحة المتنقلة لتعزيز تقديم خدمات الرعاية الصحية في الدول النامية (المملكة العربية
السعودية)
المحقق :م .نواف خان
مستشار الكلية :الدكتورة باميال مكولي
معلومات أساسية
لماذا دعيت للمشاركة في دراسة بحثية؟
ندعوك للمشاركة في هذه الدراسة البحثية ألنك مريض يزيد عمره عن  18عا ًما مصاب بداء السكري أو ارتفاع ضغط الدم.
نريد تحسين مهاراتك في إدارة األمراض المزمنة مثل السكري وارتفاع ضغط الدم .فكرة الدراسة يتم تطبيقها ألول مرة في
المملكة العربية السعودية وهي تذكير المرضى بتاريخ تعبئة األدوية ومواعيد الطبيب عن طريق تطبيق في الجوال.

لماذا يجري هذا البحث؟
يتم تعريف الصحة المتنقلة (الصحة) على أنها استخدام الهاتف الخلوي والتقنيات الالسلكية لتوفير خدمات الرعاية الطبية .نأمل
في تعزيز فعالية المنصات الصحية المتنقلة في الدول النامية لمرض السكري وارتفاع ضغط الدم من خالل إدارة التزام
المرضى بجدول إعادة تعبئة األدوية .ونأمل أيضًا في إدارة تذكير المرضى بمواعيد األطباء .باإلضافة إلى ذلك  ،نأمل في إدارة
عدد زيارات المرضى الغير ضرورية للمتابعة.

ما المدة التي سيستغرقها البحث وماذا علي أن أفعل؟
سوف تكون في هذه الدراسة لمدة شهرين .ستحتاج إلى تحميل تطبيق على جهاز  IOSالخاص بك وسوف تتفاعل مع التطبيق
لمدة  3دقائق أسبوعيًا .في البداية  ،سوف تقوم بإدخال التواريخ الخاصة بملء عبوات الدواء ومواعيد الطبيب .ثم سوف تجيب
إذا حضرتهم أم ال.

هل هناك أي طريقة في هذه الدراسة يمكن أن تكون سيئة بالنسبة لي؟
136

إن المخاطر التي تواجهك ضئيلة للغاية وال تتجاوز المخاطر المرتبطة باألنشطة الموجودة في الحياة اليومية.

هل ستساعدني هذه الدراسة على أي حال؟
ال توجد فوائد لك من مشاركتك في هذا البحث .ال يمكننا أن نعد بأي فوائد لآلخرين من مشاركتك في هذا البحث .ومع ذلك ،
تشمل الفوائد المحتملة لآلخرين مساعدتك في إدارة ارتفاع ضغط الدم أو مرض السكري.

ماذا يحدث إذا كنت ال أريد أن أكون في هذا البحث؟
المشاركة في البحث طوعية تما ًما .يمكنك أن تقرر المشاركة أو عدم المشاركة .لن يكون لقرارك بالمشاركة أو عدم المشاركة
أي تأثير على استمرار الرعاية الطبية أو العالج.

معلومات مفصلة :فيما يلي معلومات أكثر تفصي ً
ال حول هذه الدراسة باإلضافة إلى المعلومات المذكورة أعاله.
ماذا يجب أن أعرف عن دراسة بحثية؟
• شخص ما سوف يشرح لك هذه الدراسة البحثية.
• ما إذا كنت تشارك أم ال  ،فإن األمر متروك لك.
• يمكنك اختيار عدم المشاركة.
• يمكنك الموافقة على المشاركة وتغيير رأيك الح ًقا.
• لن يتم اتخاذ قرارك ضدك.
• يمكنك طرح جميع األسئلة التي تريدها قبل أن تقرر.
من الذي يمكنني التحدث إليه؟
إذا كانت لديك أسئلة أو مخاوف أو شكاوى  ،أو تعتقد أن البحث قد أضرك  ،فتحدث إلى فريق البحث على (-5555 )966+
 45359أو  nawwaf_5000@hotmail.comأو مستشار هيئة التدريس Dr. Pamela McCauley :على ) )407( 1+
 3493-567أو Pamela.McCauley@ucf.edu

تمت مراجعة هذا البحث والموافقة عليه من قبل مجلس المراجعة المؤسسية (" .)"IRBيمكنك التحدث إليهم على الرقم -407
 2901-823أو  irb@ucf.eduإذا:
• ال يتم الرد على أسئلتك أو مخاوفك أو شكاواك من قبل فريق البحث.
• ال يمكنك الوصول إلى فريق البحث.
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• تريد التحدث إلى شخص ما بجانب فريق البحث.
• لديك أسئلة حول حقوقك كموضوع بحثي.
• تريد الحصول على معلومات أو تقديم مدخالت حول هذا البحث.
كم عدد المشاركين في هذه التجربة؟
ستشمل الدراسة ما يصل إلى  350مشارك .سيكون الحد األقصى لعدد المشاركين الذين يعانون من مرض السكري ، 200
والحد األقصى لعدد المشاركين الذين يعانون من ارتفاع ضغط الدم سيكون .150
ماذا يحدث إذا قلت نعم  ،أريد أن أكون في هذا البحث؟
سيتم إجراء هذا البحث في مستشفى النور التخصصي بمكة المكرمة بالمملكة العربية السعودية .تشمل إجراءات هذا البحث:
 .1سيتحقق الباحثون من أهليتك للدراسة:
• يجب أن يكون لديك مرض السكري أو ارتفاع ضغط الدم ،
• يجب أن يكون عمرك  18عا ًما أو أكبر
• يجب أن يكون لديك جهاز محمول  IOSلتثبيت التطبيق
• ال يمكن للحوامل أو السجناء أو البالغين المصابون بضعف إدراكي أو من ليس لديهم جهاز مؤهل إلعداد الطلب في هذه
الدراسة.
 .2سوف تقوم بتوقيع نموذج الموافقة هذا  ،والذي يتضمن إذ ًنا للوصول إلى سجلك الصحي للتسجيل إذا حضرت مواعيدك
وتواريخ إعادة تعبئة الدواء.
 .3سيُطلب منك تثبيت التطبيق من متجر  Appleوسيتم عرض كيفية استخدام التطبيق.
 4سيُطلب منك تقديم معلومات سكانية وطبية عنك  ،وهي اسمك وعمرك ونوعك وسجلك الطبي ووزنك وطولك ورقم السجل
الطبي .لن تكون هناك صور أو مقاطع فيديو مطلوبة..
 .5بعد ذلك  ،سيُطلب منك إدخال تواريخ تعبئة الدواء ومواعيد الطبيب في التطبيق.
 .6بعد ذلك  ،سوف تتفاعل مع التطبيق لمدة شهرين .سيرسل لك التطبيق رسائل تذكير حول موعد تعبئة الدواء أو مواعيد
الطبيب وسيُطلب منك التسجيل عند حصولك على الدواء أو حضور موعد الطبيب .سيتلقى المحقق بيانات من التطبيق خالل
الشهرين اللذين تستخدمهما فيه .سيُطلب منك إزالة التطبيق بعد  60يو ًما من استخدامه.
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ما هي مسؤولياتي إذا شاركت في هذا البحث؟
إذا شاركت في هذا البحث  ،فسيُطلب منك التفاعل مع التطبيق فيما يتعلق بمواعيد طبيبك واألنشطة ذات الصلة بملء الدواء
خالل فترة شهرين من الدراسة .أيضًا  ،سيُطلب منك منح الباحث الرئيسي أو فريقه حق الوصول إلى السجل الطبي الخاص بك
الستخراج البيانات المتعلقة بالتزامك بمواعيد الطبيب وتواريخ إعادة تعبئة الدواء لمدة شهرين سابقين لفترة الدراسة .هذا يعني
أننا سنطلب أيضًا الوصول إلى سجلك الطبي للتسجيل إذا حضرت مواعيدك وتواريخ إعادة تعبئة الدواء.
ماذا يحدث إذا قلت نعم  ،لكنني غيرت رأيي الح ًقا؟
يمكنك ترك البحث في أي وقت لن يعقد ضدك.
هل هناك أي طريقة في هذه الدراسة يمكن أن تكون سيئة بالنسبة لي؟ (المخاطر التفصيلية)
إن المخاطر التي يتعرض لها المشاركون ضئيلة وال تتجاوز المخاطر المرتبطة باألنشطة الموجودة في الحياة اليومية.
ماذا يحدث للمعلومات التي تم جمعها للبحث؟
سيتم بذل الجهود للحد من استخدام والكشف عن معلوماتك الشخصية  ،بما في ذلك الدراسة البحثية والسجالت الطبية  ،على
األشخاص الذين يحتاجون إلى مراجعة هذه المعلومات .سيتم تأمين معلوماتك الصحية الشخصية في ملف مشفر  ،ويمكن فقط
للمؤسسات فحص ونسخ المعلومات الخاصة بك  ،بما في ذلك  IRBوممثلين آخرين لهذه المنظمة .سيتم استخدام البيانات التي
سيتم استخالصها من السجل الطبي الخاص بك من قبل الباحث الرئيسي ألغراض المقارنة لتقييم فعالية التطبيق mhealth

المستخدمة في تحقيق األهداف المعلنة الدراسة .باستثناء اسمك  ،سيتم استخدام البيانات التي ستدخلها في التطبيق (أي العمر
والجنس والتاريخ الطبي والوزن والطول) ألغراض التحليل اإلحصائي والطبقية .يوفر القانون الفيدرالي حماية إضافية
لسجالتك الطبية والمعلومات الصحية ذات الصلة .سيتم السماح لوزارة الصحة السعودية بفحص سجالت البحث بنا ًء على
الموافقة التي حصلنا عليها منها .ومع ذلك  ،ستحتاج أي لجنة محلية أخرى للحصول على الموافقة على فحص سجالت البحث.
سنطلب أيضًا الوصول إلى السجل الطبي الخاص بك  ،لتسجيل ما إذا كنت حضرت مواعيدك وتواريخ إعادة تعبئة الدواء.
هل يمكن إزالتي من البحث دون موافقتي؟
سنخبرك عن أي معلومات جديدة قد تؤثر على صحتك أو رفاهيتك أو اختيارك للبقاء في البحث.
إدارة البيانات وسريتها
سيتم حفظ البيانات في ورقة اكسل آمنة  ،وال يمكن ألحد الوصول إلى تلك البيانات باستثناء الباحث الرئيسي .سيتم إتالف
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البيانات المحددة في أقرب وقت ممكن بعد التحليل  ،ويجب االحتفاظ بالبيانات غير المحددة لمدة خمس سنوات بعد إغالق
البحث .سيتم حفظ البيانات في ورقة اكسل آمنة  ،وال يمكن ألحد الوصول إلى تلك البيانات باستثناء الباحث الرئيسي .لن يصل
التطبيق إلى أي معلومات أخرى  ،وسيُطلب منك إزالة التطبيق بعد  60يو ًما من استخدامه.
يو ّثق توقيعك إذنك بالمشاركة في هذا البحث ولكي نتمكن من الوصول إلى سجالتك الطبية.

توقيع المشارك

التاريخ

اسم المشارك
التاريخ

توقيع الباحث الرئيسي

التاريخ

اسم الباحث الرئيسي

إن توقيعي أدناه يوضح أن المعلومات الموجودة في وثيقة الموافقة وأي معلومات مكتوبة أخرى قد تم شرحها وفهمها بدقة من
قبل الموضوع وهذا الموافقة تم منحها بحرية من قبل الموضوع.

توقيع الشاهد علي عملية الموافقه

التاريخ

اسم الشاهد علي عملية الموافقه
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The Datasheet Will Be Used To Collect Information From The Medical Record For Question
Number 2
Number of
patients for 30
days

Necessary follow up

Effective clinical
appointment rate

Clinic 1
Clinic 2
Clinic 3
Clinic 4
Clinic 5
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Could be
eliminated

From

To
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An Informative Brochure On The Experiment
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Pictures of Mobile Health Application
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